EPIS® Právní systém | Plné znění

XXXXXXXX XXXXXX (XX) 2019/831

xx xxx 22. května 2019,

xxxxxx xx xxxx xxxxxxx XX, III x X xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) x. 1223/2009 x xxxxxxxxxxxx přípravcích

(Xxxx x xxxxxxxx xxx EHP)

XXXXXXXX XXXXXX,

x xxxxxxx xx Xxxxxxx x xxxxxxxxx Xxxxxxxx xxxx,

s ohledem xx nařízení Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) x. 1223/2009 xx xxx 30. xxxxxxxxx 2009 x xxxxxxxxxxxx xxxxxxxxxxx (1), x xxxxxxx xx xx. 15 xxxx. 1, xx. 15 xxxx. 2 xxxxxx xxxxxxxxxxx x xx. 31 xxxx. 1 uvedeného xxxxxxxx,

xxxxxxxx x xxxxx důvodům:

(1)

Xxxxxxxx Evropského xxxxxxxxxx x Xxxx (XX) x. 1272/2008 (2) xxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx látek jako xxxxx karcinogenních, xxxxxxxxxxx xxxx toxických xxx xxxxxxxxxx (XXX) na xxxxxxx xxxxxxxxx posouzení Xxxxxx xxx xxxxxxxxxx xxxxx Evropské agentury xxx xxxxxxxx xxxxx. Xxxxx jsou xxxxxxxxxxxxx xxxx látky XXX xxxxxxxxx 1 X, látky XXX xxxxxxxxx 1B xxxx xxxxx CMR xxxxxxxxx 2 x xxxxxxxxxx xx úrovni důkazů x xxxxxx xxxxxxxxxxxx XXX.

(2)

Xxxxxx 15 xxxxxxxx (XX) x. 1223/2009 xxxxxxxx xxxxxxxx x xxxxxxxxxxxx přípravcích xxxxx xxxxxxxxxxxxx xxxxx xxxxx 3 přílohy VI xxxxxxxx (XX) x. 1272/2008 (xxxxx CMR) xxxx xxxxx XXX xxxxxxxxx 1 X, xxxxxxxxx 1X xxxx xxxxxxxxx 2. Xxxxx XXX xxxx xxxx být v kosmetických xxxxxxxxxxx xxxxxxx, xxxxx xxxx splněny podmínky xxxxxxxxx v čl. 15 xxxx. 1 xxxxx xxxx nebo x xx. 15 xxxx. 2 druhém xxxxxxxxxxx xxxxxxxx (XX) x. 1223/2009. Xxxxx nařízením xx xxxxxxx xxxxxxxx (XX) x. 1223/2009. Vykládat xxxxx Xxxx, včetně xxxxxx 15 nařízení (XX) x. 1223/2009, xx xxxxxxxx xxxxx Soudní xxxx Xxxxxxxx xxxx.

(3)

X xxxxx jednotného xxxxxxxxx xxxxxx xxxxx XXX v rámci vnitřního xxxx, xxxxxxxxx právní xxxxxxx xxxxxxx pro xxxxxxxxxxx subjekty a příslušné xxxxxxxxxxxx xxxxxx, xxxxx x xxxxxxxxx xxxxxx xxxxxx xxxxxxx lidského xxxxxx xx xxxxxxx xxxxx XXX xxxx být xxxxxxxx xx xxxxxx xxxxxxxxxx xxxxx x xxxxxxx XX nařízení (XX) x. 1223/2009 x xxxxxxxx vyňaty xx xxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxx nebo xxxxxxxxxx xxxxx x xxxxxxxxx XXX a V uvedeného nařízení. Xxxxx xxxx xxxxxxx xxxxxxxx stanovené x xx. 15 xxxx. 1 druhé xxxx xxxx x xx. 15 odst. 2 xxxxxx pododstavci xxxxxxxx (XX) x. 1223/2009, xxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxxxx xxxxx x xxxxxxxxx XXX x X xxxxxxxxx xxxxxxxx xx xxxx xxx xxxxxxxxxxxxx způsobem xxxxxxx.

(4)	Xxxx xxxxxxxx xx xxxxxxxx xx látky, xxxxx xxxx podle xxxxxxxx (ES) x. 1272/2008 xxxxxxxxxxxxx xxxx látky XXX ke dni 1. xxxxxxxx 2018, kdy xx xxxxx xxxxxxxxxxx xxxxxxxx Xxxxxx (XX) 2017/776 (3).

(5)

Xxxxx xxx x xxxxxx xxxxx XXX, xxx xxx xxxx xxxxxxxxxx xxxxxx x xxxxxxxxx xxxxxxx v kosmetických xxxxxxxxxxx, xxxxxx xxxxxxxxx, xx xxxx splněny xxxxxxx xxxxxxxx požadované x xx. 15 odst. 1 xxxxx xxxx nebo v čl. 15 xxxx. 2 xxxxxx xxxxxxxxxxx xxxxxxxx (XX) č. 1223/2009. Xx se xxxx xxxxx Xxxxxxxxxx-15, Xxxxxxxxxxxxxxx, xxxxxxxxxxxxxx, formaldehydu, xxxxxxxxx xxxxxxxx xxxxxxxxx a perboritanů xxxxxxx.

(6)

Xxxxx methenamin-3-chlorallylchlorid, jejíž xxxxx xxxxx Xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxxx xxxxxx (XXXX) xxx Xxxxxxxxxx-15, xx x xxxxxxxx době xxxxxxx x xxxxxxx 31 xxxxxxx V nařízení (XX) x. 1223/2009 jako xxxxx xxxxxxxx x xxxxxxxxxxx do 0,2 % x xxxxxxxxx xxxxxxxxxxx x xxxxxxx. Xxxxx Xxxxxxxxxx-15 xx xxxx cis- x xxxxx-xxxxxxx, jejíž xxx-xxxxxx xxx nařízením Xxxxxx (XX) x. 790/2009 (4) xxxxxxxxxxxx xxxx látka XXX xxxxxxxxx 2. Xxxx klasifikace xx xxxxx xxxxxxxxxxx xxx 1. xxxxxxxx 2010. V souladu x xx. 15 xxxx. 1 xxxxxx xxxxx xxxxxxxx (ES) x. 1223/2009 xxxx být látka xxxxxxxxxxxxx xxxx kategorie 2 xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx, xxxx-xx xxxxxxxxxx Xxxxxxxx xxxxxxx xxx xxxxxxxxxx xxxxxxxxxxxx (dále xxx „XXXX“) x xxxxxxxx xxxx bezpečná xxx xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx. Xx dnech 13. x 14. xxxxxxxx 2011 xxxxx XXXX xxxxxxx xxxxxxxxxx xxxxxxxx xx xxxxx Xxxxxxxxxx-15 (xxx-xxxxxx) (5), ve kterém xxxxxx k závěru, xx xx xxxxxxx xxxxxxxxxx xxxxx xxxxx xxxxxxxx xxxxxxxxxx použití xxxxx Xxxxxxxxxx-15 x xxxxxxxxxxxx xxxxxxxxxxx. X xxxxxxx na xxxxxxxxxxx xxx-xxxxxxx xxxxxxxxxx x xxxxx Xxxxxxxxxx-15 jako xxxxx XXX kategorie 2 x xx stanovisko XXXX xx xxxx být xxxxx Xxxxxxxxxx-15 xxxxxx xx xxxxxxx konzervačních xxxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx v příloze V nařízení (XX) č. 1223/2009 x xxxxxxxx xx xxxxxx látek xxxxxxxxxx v kosmetických xxxxxxxxxxx x xxxxxxx II xxxxxxxxx xxxxxxxx.

(7)

Xxxxx 2-chloracetamid, xxxxx xxxxx podle INCI xxx Xxxxxxxxxxxxxxx, xx x xxxxxxxx xxxx xxxxxxx x xxxxxxx 41 přílohy X xxxxxxxx (ES) x. 1223/2009 xxxx xxxxx povolená x xxxxxxxxxxx do 0,3 % x xxxxxxxxx připraveném k použití. Xxxxx Xxxxxxxxxxxxxxx byla xxxxx nařízení (XX) x. 1272/2008 xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 2. Xxxx xxxxxxxxxxx xx stala xxxxxxxxxxx xxxx 1. prosincem 2010, xxx je xxxxx, xxx se pro xxxxx stala xxxxxxxxxx xxxxxxxxxx hlav XX, XXX a IV nařízení (XX) č. 1272/2008. X xxxxxxx x xx. 15 xxxx. 1 druhou xxxxx nařízení (ES) x. 1223/2009 xxxx být xxxxx xxxxxxxxxxxxx jako xxxxxxxxx 2 použita x xxxxxxxxxxxx xxxxxxxxxxx, byla-li xxxxxxxxxx VVBS a shledána xxxx bezpečná pro xxxxxxx v takových xxxxxxxxxxx. Xxx 22. xxxxxx 2011 xxxxx XXXX xxxxxxx xxxxxxxxxx xxxxxxxx se xxxxx Xxxxxxxxxxxxxxx (6), xx xxxxxx xxxxxx k závěru, xx xx xxxxxxx xxxxxxxxxx xxxxx xxxx tato xxxxx xxx xxxxxxx x xxxxxxxxxxx do 0,3 % xxxxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx xxx xxxxxxxxxxxx bezpečná. X xxxxxxx xx xxxxxxxxxxx xxxxx Chloroacetamide jako xxxxx XXX xxxxxxxxx 2 x xx stanovisko XXXX by xxxx xxx tato xxxxx xxxxxx xx xxxxxxx xxxxxxxxxxxxx přísad xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx X xxxxxxxx (XX) x. 1223/2009 x xxxxxxxx xx seznam xxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx v příloze XX xxxxxxxxx nařízení.

(8)

Látka xxxxxxxxxxxxx xx x xxxxxxxx xxxx xxxxxxx v položce 7 xxxxxxx XXX nařízení (XX) x. 1223/2009 xxxx xxxxx xxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxxxxxx xx 35 % x xxxxxxxxx připraveném x xxxxxxx. Xxxxxxxxxxxxx byl xxxxx xxxxxxxx (ES) x. 1272/2008 xxxxxxxxxxxx jako xxxxx XXX xxxxxxxxx 2. Xxxx klasifikace xx xxxxx xxxxxxxxxxx xxxx 1. xxxxxxxxx 2010. X xxxxxxx x xx. 15 xxxx. 1 xxxxxx xxxxx nařízení (XX) x. 1223/2009 xxxx xxx látka xxxxxxxxxxxxx xxxx kategorie 2 xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx, xxxx-xx xxxxxxxxxx XXXX x xxxxxxxx jako xxxxxxxx xxx xxxxxxx v takových xxxxxxxxxxx. Xxx 11. xxxxxxxx 2012 xxxxx XXXX vědecké xxxxxxxxxx xxxxxxxx se xxxxx dichlormethan (7). Xxx 25. xxxxxx 2015 xxxxx XXXX xxxx stanovisko (8), které xxxx revidováno dne 28. xxxxx 2015. V tomto xxxxxxxxxxx xxxxxxxxxx xxxxxx VVBS x xxxxxx, xx používání xxxxxxxxxxxxxx v koncentraci xx 35 % v lacích xx xxxxx x xxxx xxxxxxx xx xxxxxxxx xxxxxx xxxx xxxxxxxxxx za xxxxxxxx xxx xxxxxxxxxxxx. X xxxxxxx na xxxxxxxxxxx xxxxxxxxxxxxxx xxxx xxxxx XXX kategorie 2 x xx xxxxxxxxxx VVBS x xxxxxxxx x xxxx, xx xxxxxx známa x xx xxxxxxxxxx XXXX posouzena xxxxx další použití xxxxxxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx, xx xxxx xxxxx xxxx xxx xxxxxx xx xxxxxxx látek xxxxxxxxxxxxx xxxxxxx x xxxxxxx XXX xxxxxxxx (XX) x. 1223/2009 x xxxxxxxx xx xxxxxx xxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx XX xxxxxxxxx xxxxxxxx.

(9)

Xxxxx xxxxxxxxxxx xx v současné xxxx xxxxxxx x xxxxxxx 13 přílohy XXX xxxxxxxx (XX) č. 1223/2009 xxxx xxxxx xxxxxxxx x xxxxxxxxxxx pro tvrzení xxxxx x xxxxxxxxxxx xx 5 % v přípravku xxxxxxxxxxx x xxxxxxx. V současné době xx xxxx xxxxxxx x xxxxxxx 5 xxxxxxx X xxxxxxxx (ES) x. 1223/2009 xxxx látka xxxxxxxx x xxxxxxxxxxx pro xxxxx xxxxxxx x xxxxxxxxxxx do 0,1 % x x xxxxxx přípravcích x xxxxxxxxxxx do 0,2 %. Xxxxxxxxxxx xxx klasifikován xxxx xxxxx CMR xxxxxxxxx 1B nařízením Xxxxxx (EU) x. 605/2014 (9). Xxxx xxxxxxxxxxx xx xxxxx xxxxxxxxxxx xxx 1. xxxxx 2016. X xxxxxxx s čl. 15 xxxx. 2 xxxxxx pododstavcem xxxxxxxx (ES) x. 1223/2009 xxxxx xxx xxxxx xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 1 X xxxx 1B x xxxxxxxxxxxx xxxxxxxxxxx xxxxxxxxx použity, xxxxx xxxx xxxx, xx xxxx xxxxxxxxxxxxx xxxx xxxxx CMR, xxxxxxx xxxxxx xxxxxxxx xxxxxx podmínky, že xxxxxx x xxxxxxxxx xxxxx xxxxxx xxxxxxxxxxxx xxxxx, xx byla podána xxxxxx na xxxxxx xxxxxxx xxxxxxxxx xxxxxxxxx xx známou xxxxxxxx x xx xxxx tato xxxxx XXXX zhodnocena x xxxxxxxx jako xxxxxxxx. Xxx 7. xxxxxxxxx 2014 xxxxxx XXXX ve xxxx xxxxxxxxxx (10) k závěru, xx „xxx xxxxxxx nebo xxxxxxxx xxxxx xxxxx xxx xxxxxxxx xxxxxxx xxxxxxxxx xxx xxxxxxx xxxxx x xxxxxxxx koncentraci xxxxxx 2,2 % xxxxxxx xxxxxxxxxxxx“. Xxxxxxx však xxxxxx xxxxxxxxx, že xxxxxx k dispozici žádné xxxxxx alternativní xxxxx xxx xxxxxxx nehtů, xxx xx xxx xxxxxxxxxxx xxxxx xx xxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxx x xxxxxxx XXX xxxxxxxx (XX) x. 1223/2009. Xxxxxxxx x xxxx, xx xxxxxx xxxxxx xxxxxx xx xxxx xxxxxxx xxxxxxxxxxxx, měla xx xxx xxxx xxxxx xxxxxx ze xxxxxxx xxxxxxxxxxxxx přísad xxxxxxxxxx x xxxxxxxxxxxx přípravcích x xxxxxxx X xxxxxxxxx xxxxxxxx. Xxxxxxxxxxx xx xxx být xxxxxx xxxxxxx xx xxxxxx xxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx v příloze XX nařízení (XX) x. 1223/2009.

(10)

Xxxxxxxxxx xxxxxxxx xxxxxxxxx x xxxxxxxxxxx sodné patří xxxx látky uvolňující xxxxxxx xxxxxx, které xxxx x xxxxxxxx xxxx xxxxxxx x xxxxxxx 12 xxxxxxx XXX nařízení (XX) x. 1223/2009. Xxxx xxxxx byly klasifikovány xxxx xxxxx XXX xxxxxxxxx 1X xxxxxxxxx (XX) x. 790/2009. Xxxx xxxxxxxxxxx xx xxxxx xxxxxxxxxxx ke xxx 1. xxxxxxxx 2010. Xx xxxxxxx xxxxxx látek x xxxxxxxxxx xxxxxxxxxxx x xxxxxxx vlasů xxxx podána xxxxxx x xxxxxxxxx xx. 15 xxxx. 2 xxxxxxx pododstavce xxxxxxxx (XX) x. 1223/2009. Xxx 22. xxxxxx 2010 dospěl XXXX xx xxxx xxxxxxxxxx (11) x xxxxxx, že „xxxxxx xxxxxxx xxxxxx pro xxxxx, xxxxx uvolňují xxxxxxx xxxxxx, xx xx měla xxxxxxxxx xx perboritan xxxxx x xxxxxxxx perboritou x xx xxxxxxx perboritanů sodných xxxx xxxxxx x xxxxxxxxxx xxxxxxxxxxx x xxxxxxx xxxxx x xxxxxxxxxxx nejvýše 3 % xx xxxxx xxxxxxxxxxxxx xxxxxx xxx xxxxxx xxxxxxxxxxxx“. Protože však xxxxxx xxxxxxxxx, že xxxxxx x xxxxxxxxx žádné xxxxxx xxxxxxxxxxxx xxxxx xxx xxxxx xxxxxxx xxxxx, xxxxxxxxxx xxxxxxxx xxxxxxxxx x xxxxxxxxxxx xxxxx xx xxxx být xxxxxx ze xxxxxxx xxxxx xxxxxxxxxxxxx omezení x xxxxxxx XXX nařízení (XX) x. 1223/2009 a doplněny xx xxxxxx xxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx XX xxxxxxxxx xxxxxxxx.

(11)

Xxxxx xxx o určité xxxxx, jež xxxx xxxxxxxxxxxxx jako látky XXX xxxxx nařízení (XX) x. 1272/2008 x xxx xxx xxxx xxxxxx xxxxxx x xxxxxxxxx čl. 15 xxxx. 1 xxxxx xxxx xxxxxxxx (XX) x. 1223/2009, xxxx stanoveno, že xxxxxxxx xxxxxxxxx x xxxxxxxx xxxxxxxxxx je splněna. Xx se týká xxxxx Xxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxx, Xxxxxxxx a Polyaminopropyl xxxxxxxxx.

(12)

Xxxxx xxxxxxx(2,4,6-xxxxxxxxxxxxxxx)xxxxxx xxxx, xxxxx název podle XXXX xxx Xxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxx (XXX), xxxx x xxxxxxxx xxxx xx příloh xxxxxxxx (XX) č. 1223/2009 xxxxxxxx. Xxxx látka xxxx xxxxxxxxxxxxx jako látka XXX kategorie 2 xxxxxxxxx Xxxxxx (XX) x. 618/2012 (12). Xxxx xxxxxxxxxxx xx xxxxx xxxxxxxxxxx xxx 1. xxxxxxxx 2013. Dne 27. xxxxxx 2014 xxxxx XXXX xxxxxxx xxxxxxxxxx (13), v němž xxxxxx x xxxxxx, že xxxxx XXX je xxxxxxxx xxx xxxxxxx xxxx xxxxxxxxx x xxxxxxxx xxxxx v koncentraci xx 5,0 %, xxxxx xx xxx x xxxxx xxxxx xxxxxxxxxxxxxxx xxxx. Xxxxxxxx x xxxxxxxxxxxxxxxx xxxxxxx TPO xx kůži x xxxxxxxx xxxxxx xxxxxxxx v důsledku xxxxx x xxxx při xxxxxxxx xxxxxxxxx xx xxxxx xxxxxxxxx spotřebiteli xx používání XXX xxxx xxx omezeno xx xxxxxxxxxxxxx xxxxxxxxx. X xxxxxxx xx xxxx xxxxxxxxxxx xx látka XXX xxxx být xxxxxxxx xx xxxxxx xxxxx podléhajících xxxxxxx x xxxxxxx III xxxxxxxx (XX) x. 1223/2009 xxx xxxxxxxxxxxxx xxxxxxx x xxxxxxxxx xxxxxxx xxxxx x xxxxxxxxxxx xxxxxxx 5 %.

(13)

Xxxxx 2-xxxxxxxxxx, xxxxx název podle XXXX xxx Furfural, xx xxxxxxx xxxx xxxxx nebo aromatická xxxxxx x xxxxxxxxxxxx přípravcích x x xxxxxxxx době není xxxxxxxx xx xxxxxx xxxxxxxx (XX) x. 1223/2009. Xxxx látka byla xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 2 xxxxx xxxxxxxx (XX) x. 1272/2008. Xxxx xxxxxxxxxxx xx xxxxx xxxxxxxxxxx xxxx 1. prosincem 2010. Xxx 27. xxxxxx 2012 xxxxxx XXXX ve svém xxxxxxxxxx (14) x xxxxxx, xx xxxxxxx látky Xxxxxxxx x xxxxxxxxxxx xx 10 xxx (0,001 %) x xxxxxxxxx xxxxxxxxxxx k použití, včetně xxxxxxxxx pro xxxxx xxxxxxx, xxxxxxxxxxxxx riziko xxx zdraví xxxxxxxxxxxx. X xxxxxxx xx klasifikaci xxxxx Xxxxxxxx xxxx xxxxx CMR xxxxxxxxx 2 x xx stanovisko XXXX xx látka Xxxxxxxx x xxxxxxxxxxx xxxxxxx 0,001 % měla být xxxxxxxx xx seznam xxxxx podléhajících xxxxxxx x xxxxxxx XXX xxxxxxxx (XX) č. 1223/2009.

(14)

Látka polyhexamethylen-biguanid-hydrochlorid (XXXX), xxxxx xxxxx xxxxx XXXX zní Xxxxxxxxxxxxxxx xxxxxxxxx, xx x xxxxxxxx xxxx xxxxxxx xx xxxxxxx xxxx xxxxxxxxxxx xxxxxxx x xxxxxxx 28 xxxxxxx V nařízení (XX) č. 1223/2009 x xxxxxxxxxxx xxxxxxx 0,3 %. Xxxx xxxxx byla klasifikována xxxx xxxxx XXX xxxxxxxxx 2 xxxxxxxxx Xxxxxx (XX) č. 944/2013 (15). Xxxx xxxxxxxxxxx xx xxxxx xxxxxxxxxxx xxx 1. xxxxx 2015. Dne 18. xxxxxx 2014 xxxxxx XXXX stanovisko (16), xx xxxxxx xxxxxx x xxxxxx, že xx xxxxxxx dostupných xxxxx xxxxx xxxxx PHMB xxxxxxxxx xx xxxxxxxxx xxx xxxxxxxxxxxx, xxxxx xx x xxxxxxxxxxx xxxxxxx 0,3 % xxxxxxx xxxx xxxxxxxxxxx xxxxxxx x xxxxxxxxxx xxxxxxxxxxx xxxxxxxxx. Ve xxxx stanovisku xxxx XXXX xxxxxx xxxxxx x xxxxxx, že xxxxxxxx xxxxxxx xx xxxxx xxx založeno na xxxxx xxxxxxxxxxx xxxxxxx x/xxxx xxxxxxx, pokud xxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxxxx, x xx jsou xxxxxxxxx studie xxxxxxxx xxxxxxxx týkající se xxxxxxx reprezentativních xxxxxxxxxxxx xxxxxxxxx. Xxx 7. dubna 2017 xxxxxx VVBS nové xxxxxxxxxx (17), xx kterém xxxxxx x xxxxxx, xx xx xxxxxxx xxxxxxxxxxxx xxxxx se použití XXXX jako konzervační xxxxxxx xx všech xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxxxxxx xx 0,1 % xxxxxxxx xx bezpečné, ale xxxx xxxxxxx ve xxxxxxxx xx nedoporučuje. X xxxxxxx xx xxxxxxxxxxx XXXX jako látky XXX kategorie 2 x xx nové xxxxxxxxxx XXXX by xxxxx XXXX xxxx xxx xxxxxxxx xxxx xxxxxxxxxxx xxxxxxx xx xxxxx xxxxxxxxxxxx přípravcích, x xxxxxxxx xxxxxxxx, xxx xxxxx xxxx x xxxxxxxx xxxx xxxxxxxxx uživatele xxx xxxxxxxxxx, x xxxxxxxxxxx nejvýše 0,1 %. Podmínky stanovené x xxxxxxx X xxxxxxxx (XX) x. 1223/2009 xx xxxxx xxxx xxx xxxxxxxxxxxxx xxxxxxxx xxxxxxx.

(15)

Pokud xxx x xxxxxx xxxxxxx xxxxx, xxxxx xxxx xxxxxxxxxxxxx xxxx xxxxx XXX xxxxx xxxxxxxx (XX) x. 1272/2008, žádná xxxxxx xx xxxxxxxxx použití x xxxxxxxxxxxx xxxxxxxxxxx xxxxxx xxxxxxxxxx. Xxxx xxxxx xx xxxx xxx xxxxxxxx xx xxxxxx xxxxxxxxxx xxxxx v příloze XX xxxxxxxx (XX) x. 1223/2009 x xxxxxxxx xxxxxx xx xxxxxxx xxxxx xxxxxxxxxxxxx omezení xxxx xxxxxxxxxx xxxxx v přílohách XXX x X xxxxxxxxx xxxxxxxx. Xx se xxxx xxxx xxxx některých xxxxxxxxx boru, xxxxx xxxx v současné době xxxxxxx x xxxxxxxxx 1x x 1x přílohy XXX xxxxxxxx (ES) č. 1223/2009.

(16)

Xxxxxxx xxxxxxxxxx xxxx, které xxxx v současné xxxx xxxxxxx v položkách 1x x 1x xxxxxxx III xxxxxxxx (XX) x. 1223/2009, x xxxxxxxxxx-xxxxxxxxxxxxx xxxx xxxxxxxxx (XX) č. 790/2009 klasifikovány xxxx xxxxx CMR xxxxxxxxx 1X. Xxxx xxxxxxxxxxx xx xxxxx xxxxxxxxxxx xx dni 1. xxxxxxxx 2010. V souladu s čl. 15 xxxx. 2 xxxxxx xxxxxxxxxxxx xxxxxxxx (XX) č. 1223/2009 xxxxx být xxxxx xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 1 X xxxx 1B x xxxxxxxxxxxx xxxxxxxxxxx výjimečně použity, xxxxx jsou xxxx, xx xxxx klasifikovány xxxx xxxxx CMR, xxxxxxx xxxxxx podmínky. Xxx 22. června 2010 xxxxx XXXX stanovisko (18), v němž xxxxxx k závěru, xx xxxxxxx xxxxxxxxxx xxxx, xxxxx xxxx x xxxxxxxx xxxx uvedeny x xxxxxxxxx 1x x 1x xxxxxxx XXX zmíněného xxxxxxxx, xxxx xxx xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx za xxxxxxxx xxxxxxxx xxxxxxxx. Xxxxxxx xxxxxx xxxxxx xxxxxx na xxxxxx xxxxxxx x xxxxxx xxxxxxxxx, xx xxxxxx x xxxxxxxxx xxxxx xxxxxx xxxxxxxxxxxx xxxxx xxx xxxxx xxxxxxxxxxxx xxxxxxx xxxxxxxxx x xxxxxxx III nařízení (XX) x. 1223/2009, xxxx xx xxx uvedené xxxxxxxxxx xxxx xxxxxx xx xxxxxxx xxxxx xxxxxxxxxxxxx omezení x xxxxxxx XXX xxxxxxxxx nařízení x xxxxxxxx na seznam xxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx II xxxxxxxx (ES) x. 1223/2009. Xxxxx jde x xxxxxxxxxx-xxxxxxxxxxxxx, xxxxxx podána xxxxxx xx určité xxxxxxx x XXXX xx neshledal xxxx xxxxxxxxx. Xxxxxxx xxxxx xx xxxxx xxxx xxx doplněna xx seznam xxxxx xxxxxxxxxx v kosmetických přípravcích x xxxxxxx XX xxxxxxxx (XX) x. 1223/2009.

(17)

Xxxxxxxxxx xx. 31 xxxx. 1 nařízení (XX) x. 1223/2009 xxxxxxx, že xxxxxxxxxxx-xx xxxxxxx xxxxxxxx xxxxx x xxxxxxxxxxxx přípravcích xxxxxxxxxxx xxxxxx xxx xxxxxx xxxxxx, xxxxx xxxxxxxx xxxxx xx xxxxxx Společenství, xxxx Xxxxxx xx xxxxxxxxxx x XXXX xxxxxxxxxxxxx xxxxxxxx xxxxxx xxxxxxx II xx VI uvedeného xxxxxxxx. Xxxxxx konzultovala XXXX xxxxxxx xxxxxxxxxxx xxxxxxxx xxxxx, které xxxx x xxxxxxxxxx xxxxxxxx xxxxxxx látkám xxxxxxxxxxxxxx xxxx látky XXX xxxxxxxxx 1 A, 1B xxxx 2. Xx xx xxxx xxxxxxxx xxxxxxxxx xxxx, xxxxx x xxxxx xxxxxxxxxxxxxxx a methylenglykol.

(18)

Některé xxxxxxxxxx boru, v současné xxxx xxxxxxx x xxxxxxxxx 1x a 1b xxxxxxx XXX xxxxxxxx (ES) x. 1223/2009, jiné xxx xxxxxxxxxx xxxxxxx v 16. xxxx xxxxxxxxxx, nebyly xxxxxxxxxxxxx xxxx látky XXX. Dne 12. xxxxxxxx 2013 xxxxx VVBS xxxxxxxxxx xxxxxxxx se xxxxxxxx, xxxxxxxxxxxxx a oktaboritanů (19), xx xxxxxx xxxxxx x xxxxxx, xx xx xxxxxxx xxxxx, stejně xxxx xxxxxxx xxxx nebo xxxxxx kyseliny borité, xxxx je XXX-xxxxx, XXXX-xxxxxxx, boritan xxxxxxxx, xxxxxxxxxxxxxxx-xxxxx x xxxxxxx xxxxxxxxx, xxxxxxxxx xx xxxxxxx xxxxxxxxx na xxxxxxxx xxxxxxx, a proto xx xx obecná xxxxxxx xxxxxx pro xxxxxxxx xxxxxxx xxxx xxxxxxxxx xx xxxxx xxxxxxx xxxxxxxx, xxxxxxxxxxxxx x xxxxxxxxxxxx. Xxxxxxxx boritá byla xxxxxxxxx (ES) x. 790/2009 xxxxxxxxxxxxx xxxx látka XXX xxxxxxxxx 1B. Xxxx xxxxxxxxxxx xx xxxxx xxxxxxxxxxx xx xxx 1. xxxxxxxx 2010. Xxxx xxxxxxx xxxxxxxx, xxxxxxxxxxxxx x xxxxxxxxxxxx, x xxxxxxxx xxxxx x xxxxxxx skupině, které xxxx klasifikovány jako xxxxx XXX, stejně xxxx xxxxxxx xxxx xxxx xxxxxx xxxxxxxx xxxxxx xx xxxx xxx x xxxxxxx xx xxxxxxxxxx XXXX xxxxxx xx xxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxx x xxxxxxx XXX xxxxxxxx (XX) x. 1223/2009 x xxxxxxxx xx xxxxxx látek xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx XX xxxxxxxxx xxxxxxxx.

(19)

Xxxxx xxxxxxxxxxxxxxx je v současné xxxx xxxxxxx xx xxxxxxx v položce 5 xxxxxxx V nařízení (XX) x. 1223/2009, avšak xx xxxxxx xx xxxxxxxxxxxx xxxxxx xxxxxxxxxxxxx xxxx xxxxx CMR. Xxxxx xxxxxxxxxxxxxx není x xxxxxxxx xxxx xx příloh xxxxxxxx (XX) x. 1223/2009 xxxxxxxx. Ve xxxxx 26. x 27. xxxxxx 2012 přijal XXXX xxxxxxxxxx týkající xx xxxxxxxxxxxxxxx (20), ve xxxxxx xxxxxxxx, xx xxxxxxxxxxxxxx xx za xxxx xxxxxxx podmínek xxxxxx xxxxxxxxxxxx, xxx xxxx k jeho přeměně xx formaldehyd ve xxxxxxx roztocích, a že xxxxxxxxxxxxxxx xxxx xxxxxxxxxxxxxxx, xxx xxxx k jeho xxxxxxx na formaldehyd xxxxxxxx xxxx xxxxxxx. X xxxxxxx xx xxxxxxxxxx XXXX xxxxxxxx potenciální xxxxxx pro xxxxxx xxxxxx xxxxxxxxxxx x xxxxxxx xxxxxx látek v kosmetických xxxxxxxxxxx. Paraformaldehyd by xxxxx xxx xxx xxxxx xx seznamu xxxxxxxxxxxxx xxxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx v příloze X xxxxxxxx (XX) x. 1223/2009 x xxxxxxxxxxxxxxx x xxxxxxxxxxxxxx by xxxx xxx xxxxxxxx xx xxxxxx xxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx XX uvedeného xxxxxxxx.

(20)	Xxxxxxxx (ES) x. 1223/2009 xx xxxxx xxxx xxx odpovídajícím xxxxxxxx xxxxxxx.

(21)	Xxxxxxxx xxxxxxxxx xxxxx xxxxxxxxx jsou x xxxxxxx xx stanoviskem Xxxxxxx xxxxxx xxx xxxxxxxxxx xxxxxxxxx,

XXXXXXX XXXX XXXXXXXX:

Xxxxxx 1

Xxxxxxx XX, XXX x X xxxxxxxx (XX) x. 1223/2009 xx xxxx x xxxxxxx x xxxxxxxx tohoto nařízení.

Xxxxxx 2

Xxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxxxxxx dnem xx xxxxxxxxx v Úředním xxxxxxxx Evropské unie.

Xxxx xxxxxxxx xx xxxxxxx x xxxxx xxxxxxx x xxxxx xxxxxxxxxx ve xxxxx členských xxxxxxx.

X Xxxxxxx xxx 22. xxxxxx 2019.

Za Xxxxxx

xxxxxxxx

Xxxx-Xxxxxx XXXXXXX

(1)&xxxx;&xxxx;Xx.&xxxx;xxxx.&xxxx;X&xxxx;342, 22.12.2009, s. 59.

(2)&xxxx;&xxxx;Xxxxxxxx Evropského parlamentu x&xxxx;Xxxx (XX) č. 1272/2008 xx xxx 16. prosince 2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx, o změně x&xxxx;xxxxxxx xxxxxxx 67/548/XXX x&xxxx;1999/45/XX a o změně xxxxxxxx (XX) x.&xxxx;1907/2006 (Xx.&xxxx;xxxx.&xxxx;X&xxxx;353, 31.12.2008, x.&xxxx;1).

(3)&xxxx;&xxxx;Xxxxxxxx Xxxxxx (XX) 2017/776 xx xxx 4.&xxxx;xxxxxx&xxxx;2017, xxxxxx xx xxx účely xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx pokroku xxxx xxxxxxxx Evropského parlamentu x&xxxx;Xxxx (ES) č. 1272/2008 x&xxxx;xxxxxxxxxxx, označování x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx (Úř. věst. L 116, 5.5.2017, s. 1).

(4)&xxxx;&xxxx;Xxxxxxxx Xxxxxx (XX) x.&xxxx;790/2009 ze dne 10.&xxxx;xxxxx&xxxx;2009, kterým se xxx xxxxx přizpůsobení xxxxxxxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxx Evropského xxxxxxxxxx x&xxxx;Xxxx (ES) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx (Xx.&xxxx;xxxx.&xxxx;X&xxxx;235, 5.9.2009, x.&xxxx;1).

(5)&xxxx;&xxxx;XXXX/1344/10, xxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_077.xxx.

(6) SCCS/1360/10, xxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_053.xxx.

(7)&xxxx;&xxxx;XXXX/1408/11, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_118.xxx

(8)&xxxx;&xxxx;XXXX/1547/15, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_170.xxx

(9) Nařízení Xxxxxx (XX) x.&xxxx;605/2014 xx dne 5.&xxxx;xxxxxx&xxxx;2014, kterým xx xxx účely xxxxxxxx xxxxxxxxxxxx xxxxxx xxxxxxxxxx xx nebezpečnosti a bezpečného xxxxxxxxx x&xxxx;xxxxxxxxxxxx x&xxxx;xxxxxxxxxxxx xxxxxxx-xxxxxxxxxxx xxxxxxx xxxx xxxxxxxx Evropského xxxxxxxxxx x&xxxx;Xxxx (XX) č. 1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx a balení xxxxx x&xxxx;xxxxx (Xx.&xxxx;xxxx.&xxxx;X&xxxx;167, 6.6.2014, s. 36).

(10) SCCS/1538/14, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_164.xxx

(11)&xxxx;&xxxx;XXXX/1345/10, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_031.xxx

(12)&xxxx;&xxxx;Xxxxxxxx Xxxxxx (XX) x.&xxxx;618/2012 xx xxx 10.&xxxx;xxxxxxxx&xxxx;2012, xxxxxx xx xxx xxxxx xxxxxxxxxxxx xxxxxxx-xxxxxxxxxxx xxxxxxx xxxx xxxxxxxx Evropského parlamentu x&xxxx;Xxxx (ES) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, označování x&xxxx;xxxxxx xxxxx a směsí (Xx.&xxxx;xxxx.&xxxx;X&xxxx;179, 11.7.2012, x.&xxxx;3).

(13) SCCS/1528/14, http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_149.pdf.

(14)&xxxx;&xxxx;XXXX/1461/12, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_083.xxx

(15)&xxxx;&xxxx;Xxxxxxxx Xxxxxx (XX) x.&xxxx;944/2013 xx dne 2.&xxxx;xxxxx&xxxx;2013, xxxxxx xx xxx xxxxx xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (ES) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx a balení xxxxx x&xxxx;xxxxx (Xx.&xxxx;xxxx.&xxxx;X&xxxx;261, 3.10.2013, x.&xxxx;5).

(16)&xxxx;&xxxx;XXXX/1535/14, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_157.xxx

(17)&xxxx;&xxxx;XXXX/1581/16, https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_204.pdf

(18)&xxxx;&xxxx;XXXX/1249/09, https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_027.pdf

(19) SCCS/1523/13, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_146.xxx

(20)&xxxx;&xxxx;XXXX/1483/12, https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_097.pdf

XXXXXXX

1)&xxxx;&xxxx;&xxxx;

Xxxxxxx XX xx xxxx xxxxx:

xxxxxxxx xx xxxx položky, které xxxxx:

Xxxxxxxxxx xxxxx	Xxxxxxxxxxxx látky
Xxxxxxxxxx xxxxx	Chemický xxxxx/XXX	Xxxxx XXX	Xxxxx XX
x	x	x	x
„1385	Xxx-1-(3-xxxxxxxxxx)-3,5,7-xxxxxx-1-xxxxxxxxxxxxxxx-xxxxxxx (xxx-XXXX)	51229-78-8	426-020-3
1386	Xxx-1-(3-xxxxxxxxxx)-3,5,7-xxxxxx-1-xxxxxxxxxxxxxxx-xxxxxxx (xxx-XXXX), quaternium-15	51229-78-8	426-020-3
1387	2-Chloracetamid	79-07-2	201-174-2
1388	Oktamethylcyklotetrasiloxan	556-67-2	209-136-7
1389	Dichlormethan; xxxxxxxxxxxxxxx	75-09-2	200-838-9
1390	2,2′-((3,3′,5,5′-xxxxxxxxxxx-(1,1′-xxxxxxx)-4,4′-xxxx)-xxx(xxxxxxxxxxx))-xxxxxxxxx	85954-11-6	413-900-7
1391	Xxxxxxxxxxx; xxxxxxx	75-07-0	200-836-8
1392	1-Xxxxxxxxxxx-6,7-xxxxxxx-4-xxx-1,4-xxxxxxxxxxxxxxx-3-xxxxxxxxxxx xxxxxxxx	93107-30-3	413-760-7
1393	X-xxxxxx-2-xxxxxxxxxx; 1-xxxxxxxxxxxxxxxx-2-xx	872-50-4	212-828-1
1394	Xxxxxxxxxxxx; xxxx boritý	1303-86-2	215-125-8
1395	Kyselina xxxxxx [1] Xxxxxxxx boritá [2]	10043-35-3 [1] 11113-50-1 [2]	233-139-2 [1] 234-343-4 [2]
1396	Xxxxxxxx, tetraboritany, xxxxxxxxxxxx x xxxx x estery kyseliny xxxxxx, včetně:
	Oktaboritan xxxxxxx xxxxxxxxxxx [1]	12280-03-4 [1]	234-541-0 [1]
	2-xxxxxxxxxxxx, monoester x xxxxxxxxx boritou [2]	10377-81-8 [2]	233-829-3 [2]
	(2-xxxxxxxxxxxxx)xxxxxxxxxxxxxxxxxxxxxxxxxxxxx [3]	68003-13-4 [3]	268-109-8 [3]
	Xxxxxxx xxxxxxxx, xxxxxxxx sůl xxxxxxxx xxxxxx [4]	12712-38-8 [4]	603-184-6 [4]
	Xxxxxxxxxxxxxxx-xxxxx [5]	-[5]	— [5]
	Xxxxxxx xxxxxxxxx [6]	1332-07-6 [6]	215-566-6 [6]
	Xxxxxxx xxxxx, xxxxxxxxxxxx xxxxxxx xxxxxxx; xxxxx xxx kyseliny borité [7]	1330-43-4 [7]	215-540-4 [7]
	Heptaoxid xxxxxxx-xxxxxxxxxxx xxxxxx [8]	12267-73-1 [8]	235-541-3 [8]
	Xxxxx xxx xxxxxxxx xxxxxxxxxxx [9]	13840-56-7 [9]	237-560-2 [9]
	Xxxxxxxxxxxx xxxxxxx xxxxxxxxxx; xxxxx dekahydrát [10]	1303-96-4 [10]	215-540-4 [10]
	Tetraboritan xxxxxxx pentahydrát; xxxxx xxxxxxxxxxx [11]	12179-04-3 [11]	215-540-4 [11]
1397	Xxxxxxxxxx xxxxx [1] xxxxxxxxxxxxxxxxx xxxxx; xxxxxxxxxxxxx xxxxx [2]	15120-21-5 [1]	239-172-9 [1]
1397		7632-04-4 [2] 10332-33-9 [2] 10486-00-7[2]	231-556-4 [2]
1398	Kyselina xxxxxxxxx (X3XX2(X2)), xxxxxxxxx xxx, xxxxxxxxx [1]	13517-20-9 [1]	239-172-9 [1]
	kyselina perboritá, xxxxx sůl, xxxxxxxxxxx [2]	37244-98-7 [2]	234-390-0 [2]
	xxxxxxxx xxxxxxxxx (XXX(X2)), xxxxx xxx, tetrahydrát xxxxxxxxxxxxx xxxxx xxxxxxxxxx [3]	10486-00-7 [3]	231-556-4 [3]
1399	Xxxxxxxx xxxxxxxxx, xxxxx sůl [1]	11138-47-9 [1]	234-390-0 [1]
	kyselina xxxxxxxxx, xxxxx xxx, monohydrát [2]	12040-72-1 [2]	234-390-0 [2]
	xxxxxxxx xxxxxxxxx (XXX(X2)), xxxxx xxx, xxxxxxxxxx [3]	10332-33-9 [3]	231-556-4 [3]
1400	Dibutylcín-hydrogenborát	75113-37-0	401-040-5
1401	Tetrafluoroboritan xxxxxxxxx	14708-14-6	238-753-4
1402	Xxxxxxxx (XXX); mangan-N,N′-ethylenbis(dithiokarbamát), xxxxxxxxx xxxxxxx xx xxxxxxxxxx xxxx	8018-01-7	616-995-5
1403	Xxxxx (XXX); mangan-N,N′-ethylenbis(dithiokarbamát) (xxxxxxxxx)	12427-38-2	235-654-8
1404	Xxxxxxxxxxx (ISO); xxxxx-X-[({[(2,2-xxxxxxxx-2,3-xxxxxxx-1-xxxxxxxxxx-7-xx)xxx]xxxxxxxx} xxxxxxxxxxx)xxxxxxxx]-X-xxxxxxxxx-β-xxxxxxxx	82560-54-1	617-356-3
1405	X-xxxxxxxx-X-xxxxxx karbonylthiokarbamát	103122-66-3	434-350-4
1406	Chlorprofam (XXX); xxxxxxxxx-3-xxxxxxxxxxxxxxx	101-21-3	202-925-7
1407	Xxxxx-X-(xxxxxxxxxxxxxx)xxxxxxxxxxxx	109202-58-6	432-750-3
1408	Xxxxxxxxxxxxxxx-xxxxxx	13465-08-2	236-691-2
1409	(4-Xxxxxxxxxxx)[3-(3-xxxxxx-4-xxxxxxxxxx)xxxxxx]xxxxxxxxxxxxx	105024-66-6	405-020-7
1410	Xxxxx (XXX); xxxxxxx-X-[xxxxx(xxxx)xxxxxx]xxxxxxxxxxxx	14816-18-3	238-887-3
1411	Xxxxxxxxxx xxxxxx (ISO); amonium-2-amino-4-[hydroxy (xxxxxx)xxxxxxxx]xxxxxxxx	77182-82-2	278-636-5
1412	Xxxxxxx směs: xxxxxxxx-{2-[X-(xxxxxxxxxxxxx)xxxxxxxxx]xxxxx}xxxxxxxx; xxxxxxx-{2-[X-(xxxxxxxxxxxxx)xxxxxxxxx]xxxxx}xxxxxxxx; xxxxx-xxxxxx-{2-[X-(xxxxxxxxxxxxx)xxxxxxxxx]xxxxx}xxxxxxxx	—	435-960-3
1413	(4-Xxxxxxxxxx)xxxxxxxxx xxxxxxxx	86552-32-1	420-450-5
1414	Xxxxxxx xxxx: 4,7-xxx(xxxxxxxxxxxxxx)-3,6,9-xxxxxxx-1,11-xxxxxxxxxxxxxx; 4,8-xxx(xxxxxxxxxxxxxx)-3,6,9-xxxxxxx-1,11-xxxxxxxxxxxxxx; 5,7-xxx(xxxxxxxxxxxxxx)-3,6,9-xxxxxxx-1,11-xxxxxxxxxxxxxx	170016-25-8	427-050-1
1415	Xxxxxxxxxxx xxxxxxxxxx-xxxxxxxxxxxxxx(X2Xx6X13)	12056-51-8	432-240-0
1416	Xxxxx xxxxxxxxxx	71-48-7	200-755-8
1417	Xxxxxxxx xxxxxxxxxx	10141-05-6	233-402-1
1418	Xxxxxxxxx xxxxxxxxxx	513-79-1	208-169-4
1419	Xxxxxxx xxxxxxxxx	7718-54-9	231-743-0
1420	Xxxxxxxx xxxxxxxxx [1]	13138-45-9 [1]	236-068-5 [1]
1420	xxxxxxxx xxxxxxx, sůl xxxxx [2]	14216-75-2 [2]	238-076-4 [2]
1421	Xxxxxxx xxxxxxx (xxxx)	69012-50-6	273-749-6
1422	Xxxxx x xxxx x xxxxxxxxxxxxxx xxxxxxxx xxxx, xxxxxxx mědi, s xxxxxxx xxxxxx xxxxxxxxxxx	92129-57-2	295-859-3
1423	Xxxxx x xxxx z xxxxxxxxxxxxxx rafinace xxxx, xxxxxxx xxxx	94551-87-8	305-433-1
1424	Xxxxxxxxxx xxxxxxxxx; xxxxxxxx xxxxxxxxx, xxxxxxxxx xxx	13637-71-3	237-124-1
1425	Xxxxx xxxxxxxxxx-xxxxxxxxx [1]	13842-46-1 [1]	237-563-9 [1]
1425	xxxxx xxxxxxxx-xxxxxxxxx [2]	15699-18-0 [2]	239-793-2 [2]
1426	Xxxx-xxx(xxxxxxxxxx); xxxx-xxxxxxxx	13770-89-3	237-396-1
1427	Xxxxxxxxxxxxxxxxxx xxxxxxxxx	14708-14-6	238-753-4
1428	Xxxx-xxxxxxxxx [1]	3349-06-2 [1]	222-101-0 [1]
	mravenčí xxxxxxxx, xxx niklu [2]	15843-02-4 [2]	239-946-6 [2]
	xxxxxxxx xxxxxxxx, xxx xxxx x xxxxx [3]	68134-59-8 [3]	268-755-0 [3]
1429	Xxxx-xxxxxxxx [1]	373-02-4 [1]	206-761-7 [1]
1429	xxxx-xxxxxx [2]	14998-37-9 [2]	239-086-1 [2]
1430	Xxxx(XX)-xxxxxxxxx	553-71-9	209-046-8
1431	Xxxx-xxx(4-xxxxxxxxxxxxxxxxxx)	3906-55-6	223-463-2
1432	Xxxx(XX)-xxxxxxx; nikl(II)-stearát	2223-95-2	218-744-1
1433	Nikl-dilaktát	16039-61-5	—
1434	Nikl(II)-oktanoát	4995-91-9	225-656-7
1435	Fluorid nikelnatý [1]	10028-18-9 [1]	233-071-3 [1]
	bromid xxxxxxxxx [2]	13462-88-9 [2]	236-665-0 [2]
	xxxxx xxxxxxxxx [3]	13462-90-3 [3]	236-666-6 [3]
	xxxxxxx xxxxxxxx-xxxxxxxxx [4]	11132-10-8 [4]	- [4]
1436	Xxxxxxxxxxxxxxxxxxxx xxxxxxxxx	26043-11-8	247-430-7
1437	Xxxxxxx nikelnatý	15060-62-5	239-125-2
1438	Hydrogenfosforečnan nikelnatý [1]	14332-34-4 [1]	238-278-2 [1]
	xxx(xxxxxxxxxxxxxxxxxxxxx) xxxxxxxxx [2]	18718-11-1 [2]	242-522-3 [2]
	xxxxxxxxxxxxxxxx nikelnatý [3]	10381-36-9 [3]	233-844-5 [3]
	xxxxxxxxxxxxx xxxxxxxxxxx [4]	14448-18-1 [4]	238-426-6 [4]
	xxx(xxxxxxxxx) xxxxxxxxx [5]	14507-36-9 [5]	238-511-8 [5]
	xxxxxxxxxxxx niklu [6]	36026-88-7 [6]	252-840-4 [6]
	xxxxxxxx xxxxxxxxxx, xxx xxxxxxx x xxxxx [7]	17169-61-8 [7]	- [7]
	xxxxxxxx xxxxxxxxxxxx, xxxxxxxxx xxx [8]	19372-20-4 [8]	— [8]
1439	Xxxxxxxxxxxxxxxxxxxxx xxxxxxxx-xxxxxxxxx	74195-78-1	—
1440	Xxxxxx xxxxxxxxx	557-19-7	209-160-8
1441	Xxxxxxx xxxxxxxxx	14721-18-7	238-766-5
1442	Xxxxxxxxxx nikelnatý [1]	21784-78-1 [1]	244-578-4 [1]
	orthokřemičitan dinikelnatý [2]	13775-54-7 [2]	237-411-1 [2]
	xxxxxxxxxx xxxxxxxxx (3:4) [3]	31748-25-1 [3]	250-788-7 [3]
	xxxxxxxx xxxxxxxxx, xxx xxxxx [4]	37321-15-6 [4]	253-461-7 [4]
	trihydrogen-hydroxybis [xxxxxxxxxxxxx(4-)]xxxxxxxxxxxx(3-)xxxxxxxx [5]	12519-85-6 [5]	235-688-3 [5]
1443	Xxxxxxxxxxxxxxxxxxxxx xxxxxxxxxxx	14874-78-3	238-946-3
1444	Xxxxxxxxxxxxx xxxxxxxxxxxx; xxxxxxxxxx xxxxxxxxx	13477-70-8	236-771-7
1445	Xxxx(XX)-xxxxxx [1]	547-67-1 [1]	208-933-7 [1]
1445	xxxxxxxxx kyselina, sůl xxxxx [2]	20543-06-0 [2]	243-867-2 [2]
1446	Xxxxxxxx nikelnatý	12142-88-0	235-260-6
1447	Tetrasulfid triniklu	12137-12-1	—
1448	Bisarsenitan xxxxxxxxxxxx	74646-29-0	—
1449	Xxxx periklas x xxxxxxx niklu a xxxxxxx; X.X. xxxxxxxxxx xxxx 25; X.X. 77332 [1]	68186-89-0 [1]	269-051-6 [1]
	xxxxxx kobaltnato-nikelnatý [2]	58591-45-0 [2]	261-346-8 [2]
	xxxx xxxxxxx x xxxxx [3]	12737-30-3 [3]	620-395-9 [3]
1450	Xxxxxxx nikelnato-cíničitý; xxxxxxxxx xxxxxxxxx	12035-38-0	234-824-9
1451	Xxxxxxxx nikelnato-triuranový	15780-33-3	239-876-6
1452	Dithiokyanatan xxxxxxxxx	13689-92-4	237-205-1
1453	Xxxxxxxxx xxxxxxxxx	15586-38-6	239-646-5
1454	Xxxxxxxxxxx xxxxxxxxx	10101-96-9	233-263-7
1455	Xxxxxxx xxxxxxxxx	1314-05-2	215-216-2
1456	Xxxxxxxx xxxxxxxxx, xxx xxxxx x xxxxx	68130-19-8	—
1457	Xxxxxxxxx xxxxx [1]	12068-61-0 [1]	235-103-1 [1]
1457	xxxxxxx xxxxx [2]	27016-75-7 [2]	248-169-1 [2]
1458	Světle xxxxx xxxxxxxx x xxxxxxx xxxxx, barya x xxxxxx; C.I. pigmentová xxxx 157; X.X. 77900	68610-24-2	271-853-6
1459	Xxxxxxxxxx xxxxxxxxx [1]	67952-43-6 [1]	267-897-0 [1]
	xxxxxxxxx xxxxxxxxx [2]	14550-87-9 [2]	238-596-1 [2]
	xxxxx-xxxxxxxx-xxxxxx, xxxxxxxxx sůl [3]	71720-48-4 [3]	275-897-7 [3]
1460	Xxxx(XX)-xxxxxxxxxxxxxx [1]	16083-14-0 [1]	240-235-8 [1]
	nikl(II)-propionát [2]	3349-08-4 [2]	222-102-6 [2]
	nikl-bis(benzensulfonát) [3]	39819-65-3 [3]	254-642-3 [3]
	xxxx(XX)-xxxxxxxx-xxxxxx [4]	18721-51-2 [4]	242-533-3 [4]
	xxxxxxxxx xxxxxxxx, xxxxxxxxxxxxxxx sůl [5]	18283-82-4 [5]	242-161-1 [5]
	xxxxxxxxx kyselina, xxx niklu [6]	22605-92-1 [6]	245-119-0 [6]
	nikl-[bis(2-ethylhexanoát)] [7]	4454-16-4 [7]	224-699-9 [7]
	2-xxxxxxxxxxxxx kyselina, xxx xxxxx [8]	7580-31-6 [8]	231-480-1 [8]
	dimethylhexanová xxxxxxxx, xxx xxxxx [9]	93983-68-7 [9]	301-323-2 [9]
	xxxx(XX)-xxxxxxxxxxx [10]	29317-63-3 [10]	249-555-2 [10]
	xxxxxxxxxxx xxxxxxxx, xxx xxxxx [11]	27637-46-3 [11]	248-585-3 [11]
	xxxx-xxxxxxxxxxxxx [12]	84852-37-9 [12]	284-349-6 [12]
	xxxx(XX)-xxxxxxxxxxx [13]	93920-10-6 [13]	300-094-6 [13]
	nikl(II)-isodekanoát [14]	85508-43-6 [14]	287-468-1 [14]
	nikl(II)-neodekanoát [15]	85508-44-7 [15]	287-469-7 [15]
	xxxxxxxxxxx xxxxxxxx, xxx niklu [16]	51818-56-5 [16]	257-447-1 [16]
	xxxx(XX)-xxxxxxxxxxxxx [17]	93920-09-3 [17]	300-093-0 [17]
	xxx(X-xxxxxxxxx-X 1,X 2)xxxx [18]	71957-07-8 [18]	276-205-6 [18]
	xxxx-xxx(3,5-xx-xxxx-xxxxx-4-xxxxxxxxxxxxxx (1:2) [19]	52625-25-9 [19]	258-051-1 [19]
	xxxx(XX)-xxxxxxxx [20]	13654-40-5 [20]	237-138-8 [20]
	(2-xxxxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [21]	85508-45-8 [21]	287-470-2 [21]
	(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [22]	85508-46-9 [22]	287-471-8 [22]
	(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [23]	84852-35-7 [23]	284-347-5 [23]
	(2-ethylhexanoato-O)(isodekanoato-O)nikl [24]	84852-39-1 [24]	284-351-7 [24]
	(2-xxxxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [25]	85135-77-9 [25]	285-698-7 [25]
	(isodekanoato-O)(isooktanoato-O)nikl [26]	85166-19-4 [26]	285-909-2 [26]
	(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [27]	84852-36-8 [27]	284-348-0 [27]
	(isononanoato-O)(neodekanoato-O)nikl [28]	85551-28-6 [28]	287-592-6 [28]
	mastné xxxxxxxx, X6-19 xxxxxxxxxx, soli xxxxx [29]	91697-41-5 [29]	294-302-1 [29]
	xxxxxx xxxxxxxx, X8-18 x xxxxxxxxxx X18, xxxx niklu [30]	84776-45-4 [30]	283-972-0 [30]
	xxxxxxxx-2,7-xxxxxxxxxxx xxxxxxxx, xxxxxxxxx sůl [31]	72319-19-8 [31]	[31]
1461	Xxxxxxxxx nikelnatý [1]	7757-95-1 [1]	231-827-7 [1]
	xxxxxxx nikelnato-telluričitý [2]	15851-52-2 [2]	239-967-0 [2]
	xxxxxxxxx xxxxxxxxx-xxxxxxxxx [3]	15852-21-8 [3]	239-974-9 [3]
	xxxxxxxxxxx-xxxxxxxx-xxxx xxxxxxxxx x xxxxx [4]	68130-36-9 [4]	268-585-7 [4]
1462	Xxxxx xxxxx (XxX) [1]	12007-00-0 [1]	234-493-0 [1]
	borid xxxxxxx [2]	12007-01-1 [2]	234-494-6 [2]
	xxxxx xxxxxxxx [3]	12007-02-2 [3]	234-495-1 [3]
	xxxxx xxxxx [4]	12619-90-8 [4]	235-723-2 [4]
	silicid xxxxxxxxx [5]	12059-14-2 [5]	235-033-1 [5]
	xxxxxxxxx xxxxx [6]	12201-89-7 [6]	235-379-3 [6]
	xxxxxx xxxxxxx [7]	12035-64-2 [7]	234-828-0 [7]
	fosfid xxxxx x xxxx [8]	65229-23-4 [8]	[8]
1463	Xxxxxxxxx xxxxxxxxx-xxxxxxxxx [1]	12004-35-2 [1]	234-454-8 [1]
	xxxxxxx xxxxxxxxx-xxxxxxxxxx [2]	12035-39-1 [2]	234-825-4 [2]
	xxxx xxxxx x xxxxxx [3]	12653-76-8 [3]	235-752-0 [3]
	xxxxxxxx nikelnato-divanadičný [4]	52502-12-2 [4]	257-970-5 [4]
	xxxxxxxx kobaltnato-nikelnato-dimolybdenový [5]	68016-03-5 [5]	268-169-5 [5]
	xxxxxxx xxxxxxxxx-xxxxxxxxxxx [6]	70692-93-2 [6]	274-755-1 [6]
	xxxxxxxxx xxxxxxxxx-xxxxxxxxxxx [7]	14177-55-0 [7]	238-034-5 [7]
	xxxxxxxxx xxxxxxxxx-xxxxxxxxxx [8]	14177-51-6 [8]	238-032-4 [8]
	xxxxxx, xxxxxxx zeleň [9]	68515-84-4 [9]	271-112-7 [9]
	xxxxxx xxxxxxxx-xxxxxxxxx [10]	12031-65-1 [10]	620-400-4 [10]
	xxxx xxxxxxxxx x xxxxx [11]	12673-58-4 [11]	— [11]
1464	Xxxxxx-xxxxxxx-xxxx-xxxx	—	442-750-5
1465	Xxxx xxxxxxxxxxx	1313-27-5	215-204-7
1466	Xxxxxxxxxxxxxxxxxxx (XXXX)	683-18-1	211-670-0
1467	4,4′-xxx(X-xxxxxxxxx-4-xxxxxxxxxxxxxxxxxxxxxx) xxxxxxxxxxxxx	151882-81-4	418-770-5
1468	Xxxxxxxxxxxxxxx; (2-xxxxx)xxxxxxxx	98-00-0	202-626-1
1469	1,2-Xxxxx-4-(1,2-xxxxxxxxxx)xxxxxxxxxx; 4-vinylcyklohexendiepoxid	106-87-6	203-437-7
1470	6-Glycidyloxynaft-1-yl-oxymethyloxiran	27610-48-6	429-960-2
1471	2-(2-Aminoethylamino)ethanol (XXXX)	111-41-1	203-867-5
1472	1,2-Xxxxxxxxxxxxx	629-14-1	211-076-1
1473	(2,3-Xxxxxxxxxxx)xxxxxxxxxxxxxxxx-xxxxxxx; xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx	3033-77-0	221-221-0
1474	1-(2-Xxxxx-5-xxxxxxxxxx)-2,2,2-xxxxxxxxxxxxx-1,1-xxxx-xxxxxxxxxxxx	214353-17-0	433-580-2
1475	(X)-3-[1-[4-[2-(xxxxxxxxxxxxx)xxxxxx]xxxxx]-2-xxxxxxxx-1-xxxx]xxxxx	82413-20-5	428-010-4
1476	4,4′-[1,3-Xxxxxxxxxx(1-xxxxxxxxxxxxx)]xxxxxxx	13595-25-0	428-970-4
1477	2-Xxxxx-6-xxxxxxxxxx	2040-90-6	433-890-8
1478	5-Xxxx-xxxxx-2-xxxxxxxxxxxx-1-xxxxx	—	444-970-7
1479	2-Xxxxxxx-3-xxxxxxx-5-xxxxxxxxxxxxxx-3-xx-xxxxxxxx-2-xx-1-xx	94723-86-1	425-150-8
1480	Xxxxxxxxxx (XXX); 2-{(XX)-1-[(2XX)-2-(4-xxxxxxxxxxxx) xxxxxxxxxxxx]xxxxx}-3-xxxxxxx-5-(xxxxx-3-xx)xxxxxxxx-2-xx-1-xx	139001-49-3	604-105-8
1481	Xxxxxxxxxxxx (ISO); (XX)-(XX)-2-{1-[(2X)-3-xxxxxxxxxxxxxxxxxx]xxxxxx}-3-xxxxxxx-5-xxxxxxxxxxxxx-4-xxxxxxxxxx-2-xx-1-xx	149979-41-9	604-715-4
1482	3,3-(Xxxxxxxxxxxx)xxxxx-5(10),9(11)-xxxx-17-xx	5571-36-8	427-230-8
1483	Xxxxxxxx-1,4,9(11)-xxxxx-3,17-xxxx	15375-21-0	433-560-3
1484	Xxxxxxx xxxx: kalcium-alkylsalicyláty (xxxxxxxxxx xxxxxx C10-C14 x X18-X30); xxxxxxx-xxxxxxxxxxxxx (xxxxxxxxxx xxxxxx C10-C14 a X18-X30); xxxxxxx-xxxxxxxxxxxxxxxxxxx (rozvětvené xxxxxx X10-X14 x X18-X30)	—	415-930-6
1485	Xxxxxxxx 1,2-xxxxxxxxxxxxxxxxxxx; xxxxxxx-(xxxxxx X6-X8)xxxxxx, xxxxxxxxxx, xxxxxx xx X7	71888-89-6	276-158-1
1486	Xxxxxxx xxxx: xxxxxxx 4,4′-xxxxxxxxxxxx[2-(2-xxxxxxx-5-xxxxxxxxxxxx)-3,6-xxxxxxxxxxxxxx] x xxxxxxxx 6-diazo-5,6-dihydro-5-oxonaftalen-1-sulfonové (1:2); xxxxxxxx 4,4′-methylenbis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylfenolu] x xxxxxxxx 6-xxxxx-5,6-xxxxxxx-5-xxxxxxxxxxx-1-xxxxxxxxx (1:3)	—	427-140-9
1487	Diamonium 1-xxxxxxx-2-(4-(4-xxxxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx)-7-xxxxx-3-xxxxxxxxxxxxxxxx	150202-11-2	422-670-7
1488	Xxxxxxxx 3-xxxxxxxxxx-4-xx-17-β -xxxxxxxxxxx	302-97-6	414-990-0
1489	Xxxxxxxx (X)-2-xxxxxxxxxxx-2-[2-(xxxxxxxxxxx)xxxxxxx-4-xx]xxxxxx	64485-90-1	431-520-1
1490	Xxxxxxxxxx-xxxxxxxxxxxxxxxx	5064-31-3	225-768-6
1491	2-Xxxxxxxxxx-(2-xxxxxxxxxxxxx)	7425-14-1	231-057-1
1492	Xxxxxxxxxx-xxxxxx	84-69-5	201-553-2
1493	Xxxxxxxxxxxxxxxxxxxxxx xxxxxxxx; heptadekafluoroktan-1-sulfonová xxxxxxxx [1]	1763-23-1 [1]	217-179-8 [1]
	xxxxxx-xxxxxxxxxxxxxxxxxxxxx; xxxxxx-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxx [2]	2795-39-3 [2]	220-527-1 [2]
	diethanolamin-perfluoroktansulfonát [3]	70225-14-8 [3]	274-460-8 [3]
	xxxxxxx-xxxxxxxxxxxxxxxxxxxxx; xxxxxxx-xxxxxxxxxxxxxxxxxxxxxxxxxxx [4]	29081-56-9 [4]	249-415-0 [4]
	xxxxxxx-xxxxxxxxxxxxxxxxxxxxx; xxxxxxx-xxxxxxxxxxxxxxxxxxxxxxxxxxx [5]	29457-72-5 [5]	249-644-6 [5]
1494	Xxxxx-[1-(2,4-xxxxxxxxxxxx)5-(xxxxxxxxxxxxxx)-1X-1,2,4-xxxxxxx-3-xxxxxxxxxx]	103112-35-2	401-290-5
1495	1-Xxxx-2-xxxxxxxxxxxxxxxxxxxxx	158894-67-8	422-900-6
1496	1-Xxxxxxxxxxxxxxx-xxxxxxxxxxxxx	99464-83-2	444-950-8
1497	6,6′-Xxx(xxxxx-5,5′,6,6′-xxxxxxxxxx-5,5′-xxxxx)[xxxxxxxxxxx(5-(6-xxxxx-5,6-xxxxxxx-5-xxx-1-xxxxxxxxxxxxxxxxx)-6-xxxxxx-2-xxxxxxx]xx(xxxxxxxx-1-xxxxxxxx)	—	441-550-5
1498	Xxxxxxxxxxx (XXX); α,α,α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidin; 2,6-xxxxxxx-X,X-xxxxxxxx-4-(xxxxxxxxxxxxxx)xxxxxx; X,X-xxxxxxxx-2,6-xxxxxxx-4-(xxxxxxxxxxxxxx)xxxxxx	1582-09-8	216-428-8
1499	4-Xxxxx-2-xxxxxxxxxxx	1671-49-4	430-550-0
1500	Xxxxxxxxxx-4-[(4-[1-xxxxxxx-7-(4-xxxxxxxxxxxxxxxxxx)-3-xxxxxxxxx-2-xxxxxx]xxx-2,5-xxxxxxxxxxxxxx)xxx]xxxxxxx	221354-37-6	432-270-4
1501	Xxxxxxx xxxx: xxxxxxxxxx-6-xxxxx-3-({2,5-xxxxxxxx-4-[(3-xxxxxxxxxxxx)xxx]xxxxx}xxx)-4-xxxxxxxxxxxxxxx-2-xxxxxxxx; xxxxxxxxx-3-({4-[(7-xxxxx-1-xxxxxxx-3-xxxxx-2-xxxxxx)xxx]-2,5-xxxxxxxxxxxxx}xxx)xxxxxxx	163879-69-4	438-310-7
1502	X,X′-(xxxxxxx-4,4′-xxxx)xxxxxxxxxxx	613-35-4	210-338-2
1503	Xxxxxxxxxxxxxx	108-91-8	203-629-0
1504	Xxxxxxxxx	110-85-0	203-808-3
1505	Xxxxxxxxxxxx	7803-49-8	232-259-2
1506	Xxxxxxxxxxxxxxx-xxxxxxx; xxxxxxxxxxxx-xxxxxxxxxxxx [1]	5470-11-1 [1]	226-798-2 [1]
1506	xxx(xxxxxxxxxxxxxxx-xxxxxx); xxxxxxxxxxxx-xxxxxx (2:1) [2]	10039-54-0 [2]	233-118-8 [2]
1507	Xxxxxxxxxxxxxxxxxxx; diaminotoluen	—	—
1508	Mepanipyrim; 4-xxxxxx-X-xxxxx-6-(1-xxxxxxxx)-2-xxxxxxxxxxxxx	110235-47-7	600-951-7
1509	Xxxxxxxxxxxxxxx-xxxxxxxxxxxxxx; xxxxxxxxxxxx-xxxxxx (1:1) [1]	10046-00-1 [1]	233-154-4 [1]
	hydroxylamin-fosfát [2]	20845-01-6 [2]	244-077-0 [2]
	xxxxxxxxxxxx-xxxxxxxxxxxxxxxx [3]	19098-16-9 [3]	242-818-2 [3]
	xxxxxxxxxxxx-4-xxxxxxxxxxxx-1-xxxxxxxx [4]	53933-48-5 [4]	258-872-5 [4]
1510	(3-Xxxxx-2-xxxxxxxxxxxxx)xxxxxxxxxxxxxxxx-xxxxxxx	3327-22-8	222-048-3
1511	Xxxxxxx-3,3′,4,4′-xxxxxxxx; 3,3′-xxxxxxxxxxxxxxx	91-95-2	202-110-6
1512	Xxxxxxxxx-xxxxxxxxxxxx [1]	6094-40-2 [1]	228-042-7 [1]
	xxxxxxxxx-xxxxxxxxxxxxxx [2]	142-64-3 [2]	205-551-2 [2]
	xxxxxxxxx-xxxxxx [3]	1951-97-9 [3]	217-775-8 [3]
1513	3-(Xxxxxxxxx-1-xx)-xxxxx[x]xxxxxxxxxx-xxxxxxxxxxxx	87691-88-1	421-310-6
1514	(2-Xxxxxxxxxx)xxxxxxxx-xxxxxxxxxxxx	19398-06-2	421-460-2
1515	(2-Xxxxxxxxxx)(3-xxxxxxxxxxxxx)xxxxxxx-xxxxxxx	40722-80-3	429-740-6
1516	4-[(3-Xxxxxxxxxx)(xxxxxxxx-1-xx)xxxxxx]xxxxxx-1,2-xxxxxxxxxxxxxxxxxxxx	159939-85-2	425-030-5
1517	Xxxxx-X,X-xxxxxxxxxxxxxxxxxxx-xxxxxxx	3724-43-4	425-970-6
1518	7-Xxxxxxx-6-[3-(xxxxxxxx-4-xx)xxxxxxx]xxxxxxxxxx-4(3X)-xx;	199327-61-2	429-400-7
1519	Xxxxxxxx reakce xxx(2-xxxxxxxxxxxxx) xxxxx x xxxxxxxxxxxxx (1:4)	220444-73-5	432-440-8
1520	3-Xxxxx-4-[(3-xxxxxxxxxxx)xxx]xxxxxx	202197-26-0	445-590-4
1521	Xxxxxxxxxxxxxx; 3,8-Xxxxxxx-1-xxxxx-6-xxxxxxxxxxxxxxxxxxxx-xxxxxx	1239-45-8	214-984-6
1522	(2XX)-2-xxxxx-3,3-xxxxxxxxxxxxxxxxx	144177-62-8	447-860-7
1523	9-Xxxxxxxxxxxxx-3-xxxx; (9-Xxxxxxxxxxxxx-3-xx)xxxx	132-32-1	205-057-7
1524	(6X-xxxxx)-1-((7-xxxxxx-2-xxxxxxxxxxx-8-xxx-5-xxxx-1-xxxxxxxxxx-[4.2.0]xxx-2-xx-3-xx)xxxxxx)xxxxxxxxxx-xxxxx	100988-63-4	423-260-0
1525	Xxxxxxxxxxxxxxx (XXX); 1-(2-xxxxx-4-xxxxxxx)-3-xxxxxxxxxxxxx	68157-60-8	614-346-0
1526	1,3-Xxxxxxxxxxxxxxxxxxxxxxxxxxx-2(1X)-xx; xxxxxxxxxxxxxxxxxxxxxxxx	7226-23-5	230-625-6
1527	Xxxxxxxx	91-22-5	202-051-6
1528	Xxxxxxxxxxx; 1-[4-(4-{[(2XX,4XX)-2-(2,4-xxxxxxxxxxxx)-2-(xxxxxxxx-1-xxxxxxxx)-1,3-xxxxxxxx-4-xx]xxxxxxx} fenyl)piperazin-1-yl]ethan-1-on	65277-42-1	265-667-4
1529	Metkonazol (XXX); (1XX,5XX;1XX,5XX)-5-(4-xxxxxxxxxxx)-2,2-xxxxxxxx-1-(1X-1,2,4-xxxxxxx-1-xxxxxxxx)xxxxxxxxxxx-1-xx	125116-23-6	603-031-3
1530	Xxxxxx-1-xxxxxx-4-{3-[1-xxxxxx-3-(xxxxxxxxxxxxxxxxx)-5-xxx-4,5-xxxxxxxxxxxxxx-4-xxxxxx]xxxx-1-xx-1-xx}-3-(xxxxxxxxxxxxxxxxx)xxxxxxx-5-xxxx	183196-57-8	418-260-2
1531	1,3,5-Xxxx(2,3-xxxxx-2-xxxxxxxxxxxx)-1,3,5-xxxxxxx-2,4,6(1X,3X,5X)-xxxxx	26157-73-3	435-010-8
1532	2,2-Xxx(xxxxxxxxxxxxx)xxxxx-1-xx-xxxx[3-(xxxxxxxx-1-xx)xxxxxxxxx]; (XXX)	52234-82-9	257-765-0
1533	4,4′-Xxxxxxxxxxxxxxx diisokyanát; xxxxxxxxxxxxx-4,4′-xxxxxxxxxxx [1]	101-68-8 [1]	202-966-0 [1]
	2,2′-xxxxxxxxxxxxxxx xxxxxxxxxxx; xxxxxxxxxxxxx-2,2′-xxxxxxxxxxx [2]	2536-05-2 [2]	219-799-4 [2]
	x-(x-xxxxxxxxxxxxxxxx)xxxxx xxxxxxxxx; difenylmethan-2,4′-diisokyanát [3]	5873-54-1 [3]	227-534-9 [3]
	xxxxxxxxxxxxxxx-xxxxxxxxxxx [4]	26447-40-5 [4]	247-714-0 [4]
1534	Xxxxxxx xxxxx (XXX); xxxxx-(X)-2-xxxxx-3-[2-xxxxx-5-(xxxxxxxx-1-xx-1,2-xxxxxxxxxxxxx)xxxxx]xxxxxxx	142891-20-1	604-318-6
1535	X-[6,9-xxxxxxx-9-[[2-xxxxxxx-1-(xxxxxxxxxxxxx)xxxxxx]xxxxxx]-6-xxx-1X-xxxxx-2-xx]xxxxxxxx	84245-12-5	424-550-1
1536	Xxxxxxxxxxxxx (XXX); (X)-2-(xxxxxxxxxxxx)-X-xxxxxx-2-[α-(2,5-xxxxxxxx)-x-xxxxx]xxxxxxxx	149961-52-4	604-712-8
1537	2-(Xxxxxxxxxxxxx)xxxxxxxxxxxxxxxxxxxxxxxx	27366-72-9	435-470-1
1538	Xxxxxxx směs: 2,2′-[(3,3′-xxxxxxxxxxxxxx-4,4′-xxxx)xxxxxx]xxx[X-(2,4-xxxxxxxxxxxxx)-3-xxxxxxxxxxxx]; X-(2,4-xxxxxxxxxxxxx)-X′-(2-xxxxxxxxxxx)-2,2′-[(3,3′-xxxxxxxxxxxxxx-4,4′-xxxx)xxxxxx]xxx(3-xxxxxxxxxxxx); 2-[[3,3′-dichlor-4′-[[1[[(2,4-dimethylfenyl)amino]karbonyl]-2-oxopropyl]azo][1,1′-bifenyl]-4-yl]azo]-N-(2-karboxylfenyl)-3-oxo-butanamid		434-330-5
1539	Ropa, xxxx, xxxxx x xxxxx xxxx x jejich xxxxxxxx xxxxxxxxxx xx xxxxxxx xxxxxxxxx x/xxxx xxxxxx xxxxx xxxxxxxxxx, xxxxx obsahují ≥ 0,1 % xxxxxxxxxxxx xxxxxxx	85536-20-5 85536-19-2 90641-12-6 90989-38-1 91995-20-9 92062-36-7 91995-61-8 101316-63-6 93821-38-6 90641-02-4 101316-62-5 90641-03-5 65996-79-4 101794-90-5 90640-87-2 84650-03-3 65996-82-9 90641-01-3 65996-87-4 90640-99-6 68391-11-7 92062-33-4 91082-52-9 68937-63-3 92062-28-7 92062-27-6 91082-53-0 91995-31-2 91995-35-6 91995-66-3 122070-79-5 122070-80-8 65996-78-3 94114-52-0 94114-53-1 94114-54-2 94114-56-4 94114-57-5 90641-11-5 8006-61-9 8030-30-6 8032-32-4 64741-41-9 64741-42-0 64741-46-4 64742-89-8 68410-05-9 68514-15-8 68606-11-1 68783-12-0 68921-08-4 101631-20-3 64741-64-6 64741-65-7 64741-66-8 64741-70-4 64741-84-0 64741-92-0 68410-71-9 68425-35-4 68527-27-5 91995-53-8 92045-49-3 92045-55-1 92045-58-4 92045-64-2 101316-67-0 64741-54-4 64741-55-5 68476-46-0 68783-09-5 91995-50-5 92045-50-6 92045-59-5 92128-94-4 101794-97-2 101896-28-0 64741-63-5 64741-68-0 68475-79-6 68476-47-1 68478-15-9 68513-03-1 68513-63-3 68514-79-4 68919-37-9 68955-35-1 85116-58-1 91995-18-5 93571-75-6 93572-29-3 93572-35-1 93572-36-2 64741-74-8 64741-83-9 67891-79-6 67891-80-9 68425-29-6 68475-70-7 68603-00-9 68603-01-0 68603-03-2 68955-29-3 92045-65-3 64742-48-9 64742-49-0 64742-73-0 68410-96-8 68410-97-9 68410-98-0 68512-78-7 85116-60-5 85116-61-6 92045-51-7 92045-52-8 92045-57-3 92045-61-9 92062-15-2 93165-55-0 93763-33-8 93763-34-9 64741-47-5 64741-48-6 64741-69-1 64741-78-2 64741-87-3 64742-15-0 64742-22-9 64742-23-0 64742-66-1 64742-83-2 64742-95-6 68131-49-7 68477-34-9 68477-50-9 68477-53-2 68477-55-4 68477-61-2 68477-89-4 68478-12-6 68478-16-0 68513-02-0 68516-20-1 68527-21-9 68527-22-0 68527-23-1 68527-26-4 68603-08-7 68606-10-0 68783-66-4 68919-39-1 68921-09-5 85116-59-2 86290-81-5 90989-42-7 91995-38-9 91995-41-4 91995-68-5 92045-53-9 92045-60-8 92045-62-0 92045-63-1 92201-97-3 93165-19-6 94114-03-1 95009-23-7 97926-43-7 98219-46-6 98219-47-7 101316-56-7 101316-66-9 101316-76-1 101795-01-1 102110-14-5 68476-50-6 68476-55-1 90989-39-2	287-502-5 287-500-4 292-636-2 292-694-9 295-281-1 295-551-9 295-323-9 309-868-8 298-725-2 292-625-2 309-867-2 292-626-8 266-013-0 309-971-8 292-609-5 283-483-2 266-016-7 292-624-7 266-021-4 292-622-6 269-929-9 295-548-2 293-766-2 273-077-3 295-543-5 295-541-4 293-767-8 295-292-1 295-295-8 295-329-1 310-170-0 310-171-6 266-012-5 302-688-0 302-689-6 302-690-1 302-692-2 302-693-8 292-635-7 232-349-1 232-443-2 232-453-7 265-041-0 265-042-6 265-046-8 265-192-2 270-077-5 271-025-4 271-727-0 272-186-3 272-931-2 309-945-6 265-066-7 265-067-2 265-068-8 265-073-5 265-086-6 265-095-5 270-088-5 270-349-3 271-267-0 295-315-5 295-430-0 295-436-3 295-440-5 295-446-8 309-871-4 265-055-7 265-056-2 270-686-6 272-185-8 295-311-3 295-431-6 295-441-0 295-794-0 309-974-4 309-987-5 265-065-1 265-070-9 270-660-4 270-687-1 270-794-3 270-993-5 271-008-1 271-058-4 272-895-8 273-271-8 285-509-8 295-279-0 297-401-8 297-458-9 297-465-7 297-466-2 265-075-6 265-085-0 267-563-4 267-565-5 270-344-6 270-658-3 271-631-9 271-632-4 271-634-5 273-266-0 295-447-3 265-150-3 265-151-9 265-178-6 270-092-7 270-093-2 270-094-8 270-988-8 285-511-9 285-512-4 295-432-1 295-433-7 295-438-4 295-443-1 295-529-9 296-942-7 297-852-0 297-853-6 265-047-3 265-048-9 265-071-4 265-079-8 265-089-2 265-115-2 265-122-0 265-123-6 265-170-2 265-187-5 265-199-0 268-618-5 270-725-7 270-735-1 270-736-7 270-738-8 270-741-4 270-771-8 270-791-7 270-795-9 270-991-4 271-138-9 271-262-3 271-263-9 271-264-4 271-266-5 271-635-0 271-726-5 272-206-0 272-896-3 272-932-8 285-510-3 289-220-8 292-698-0 295-298-4 295-302-4 295-331-2 295-434-2 295-442-6 295-444-7 295-445-2 296-028-8 296-903-4 302-639-3 305-750-5 308-261-5 308-713-1 308-714-7 309-862-5 309-870-9 309-879-8 309-976-5 310-012-0 270-690-8 270-695-5 292-695-4
1540	Xxxx, xxxx, xxxxx x xxxxx plyn x xxxxxx deriváty xxxxxxxxxx xx xxxxxxx xxxxxxxxx a/nebo xxxxxx xxxxx xxxxxxxxxx, xxxxx xxxxxxxx ≥ 0,005 % hmotnostních benzo[a]pyrenu
		90640-85-0 92061-93-3 90640-84-9 61789-28-4 70321-79-8 122384-77-4 70321-80-1	292-606-9 295-506-3 292-605-3 263-047-8 274-565-9 310-189-4 274-566-4
1541	Ropa, xxxx, dehet a xxxxx plyn a xxxxxx deriváty generované xx xxxxxxx xxxxxxxxx x/xxxx xxxxxx xxxxx xxxxxxxxxx, xxxxx xxxxxxxx ≥ 0,1 % xxxxxxxxxxxx benzenu xxxx xxxxx xxxxxxxx ≥ 0,005 % xxxxxxxxxxxx xxxxx[x]xxxxxx
		85029-51-2 84650-04-4 84989-09-3 91995-49-2 121620-47-1 121620-48-2 90640-90-7 90641-04-6 101896-27-9 101794-91-6 91995-48-1 90641-05-7 84989-12-8 121620-46-0 90640-81-6 90640-82-7 92061-92-2 91995-15-2 91995-16-3 91995-17-4 101316-87-4 122384-78-5 84988-93-2 90640-88-3 65996-83-0 90640-89-4 90641-06-8 65996-85-2 101316-86-3 92062-22-1 96690-55-0 84989-04-8 84989-05-9 84989-06-0 84989-03-7 84989-07-1 68477-23-6 68555-24-8 91079-47-9 92062-26-5 94114-29-1 90641-00-2 68513-87-1 70321-67-4 92062-29-8 100801-63-6 100801-65-8 100801-66-9 73665-18-6 68815-21-4 65996-86-3 65996-84-1	285-076-5 283-484-8 284-898-1 295-310-8 310-166-9 310-167-4 292-612-1 292-627-3 309-985-4 309-972-3 295-309-2 292-628-9 284-901-6 310-165-3 292-603-2 292-604-8 295-505-8 295-275-9 295-276-4 295-278-5 309-889-2 310-191-5 284-881-9 292-610-0 266-017-2 292-611-6 292-629-4 266-019-3 309-888-7 295-536-7 306-251-5 284-892-9 284-893-4 284-895-5 284-891-3 284-896-0 270-713-1 271-418-0 293-435-2 295-540-9 302-662-9 292-623-1 271-020-7 274-560-1 295-544-0 309-745-9 309-748-5 309-749-0 277-567-8 272-361-4 266-020-9 266-018-8
1542	Xxxx, uhlí, dehet x xxxxx xxxx x xxxxxx xxxxxxxx xxxxxxxxxx xx použití xxxxxxxxx x/xxxx xxxxxx xxxxx xxxxxxxxxx, xxxxx xxxxxxxx ≥ 0,1 % xxxxxxxxxxxx xxxx-1,3-xxxxx
		68607-11-4 68783-06-2 68814-67-5 68814-90-4 68911-58-0 68911-59-1 68919-01-7 68919-02-8 68919-03-9 68919-04-0 68919-07-3 68919-08-4 68919-11-9 68919-12-0 68952-79-4 68952-80-7 68955-33-9 68989-88-8 92045-15-3 92045-16-4 92045-17-5 92045-18-6 92045-19-7 92045-20-0 68131-75-9 68307-98-2 68307-99-3 68308-00-9 68308-01-0 68308-10-1 68308-03-2 68308-04-3 68308-05-4 68308-06-5 68308-07-6 68308-09-8 68308-11-2 68308-12-3 68409-99-4 68475-57-0 68475-58-1 68475-59-2 68475-60-5 68476-26-6 68476-29-9 68476-40-4 68476-42-6 68476-49-3 68476-85-7 68476-86-8 68477-33-8 68477-35-0 68477-69-0 68477-70-3 68477-71-4 68477-72-5 68308-08-7	271-750-6 272-182-1 272-338-9 272-343-6 272-775-5 272-776-0 272-873-8 272-874-3 272-875-9 272-876-4 272-880-6 272-881-1 272-884-8 272-885-3 273-173-5 273-174-0 273-269-7 273-563-5 295-397-2 295-398-8 295-399-3 295-400-7 295-401-2 295-402-8 268-629-5 269-617-2 269-618-8 269-619-3 269-620-9 269-630-3 269-623-5 269-624-0 269-625-6 269-626-1 269-627-7 269-629-8 269-631-9 269-632-4 270-071-2 270-651-5 270-652-0 270-653-6 270-654-1 270-667-2 270-670-9 270-681-9 270-682-4 270-689-2 270-704-2 270-705-8 270-724-1 270-726-2 270-750-3 270-751-9 270-752-4 270-754-5 269-628-2
1543	Xxxx[2-xxxxx-1-(xxxxxxxxxxx)xxxxx]xxxxxx	13674-87-8	237-159-2
1544	Xxxxxx xxxxx	22398-80-7	244-959-5
1545	Xxxxxxxx-xxxxxx	25155-23-1	246-677-8
1546	Xxxxxxxxxxxxxxxxxxxx [1]	25637-99-4 [1]	247-148-4 [1]
1546	1,2,5,6,9,10-xxxxxxxxxxxxxxxxxxxx [2]	3194-55-6 [2]	221-695-9 [2]
1547	Xxxxxxxxxxxxxxx	109-99-9	203-726-8
1548	Xxxxxxxxx (směs xxxxxxxxxxx X1x a xxxxxxxxxxx X1x) (XXX) [1]	71751-41-2 [1]	615-339-5 [1]
1548	xxxxxxxxxx X1x [2]	65195-55-3 [2]	265-610-3 [2]
1549	4-Terc-butylbenzoová xxxxxxxx	98-73-7	202-696-3
1550	Xxxxxxxxxxxxxxxx xxxxx; X,X,X′,X′-xxxxxxxxxxx-4,4′-xxxxxxxxxxxxxxxxxx	129-73-7	204-961-9
1551	Xxxxxxxxxxx (XXX); 2-(2-furyl)benzimidazol	3878-19-1	223-404-0
1552	Metazachlor (XXX); 2-xxxxx-X-(2,6-xxxxxxxxxxxxx)-X-(xxxxxxx-1-xxxxxxxx)xxxxxxxx	67129-08-2	266-583-0
1553	Xx-xxxx-xxxxxxxxxxxx	110-05-4	203-733-6
1554	Xxxxxxxxxxxxxxxxxxxxx	993-16-8	213-608-8
1555	2-Xxxxxxxxxx-10-xxxxx-4-[[2-[(2-xxxxxxxxxx)xxx]-2-xxxxxxxx]xxxx]-4-xxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxx	57583-34-3	260-828-5
1556	2-Xxxxxxxxxx-(10-xxxxx-4,4-xxxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxx)	15571-58-1	239-622-4
1557	Xxxxxxxxxx (XXX); 2-[2-xxxxx-4-(xxxxxxxxxxxxxx)xxxxxxx]xxxxxxxxxx-1,3-xxxx	99105-77-8	619-394-6
1558	Xxxxxxxxxx (XXX); (2-xxxxxxxxxxxxx-3-xx)xxxxxx-xxx-(1X,3X)-3-[(1X)-2-xxxxx-3,3,3-xxxxxxxxxxxx-1-xx-1-xx]-2,2-xxxxxxxxxxxxxxxxxxx-xxxxxxxxxx	82657-04-3	617-373-6
1559	Xxxxxxx-xxxxxx	84-75-3	201-559-5
1560	Xxxxxxx-xxxxxxxxxxxxxxxxxxxxxx	3825-26-1	223-320-4
1561	Xxxxxxxxxxxxxxxx kyselina	335-67-1	206-397-9
1562	N-ethyl-2-pyrrolidon; 1-xxxxxxxxxxxxxxx-2-xx	2687-91-4	220-250-6
1563	Xxxxxxxxxxx (XXX); 6-xxx-2-xxxxxxx-3-xxxxxxxxxxxxxxxx-4(3X)-xx	189278-12-4	606-168-7
1564	Xxxxxxx xxxxx	1303-00-0	215-114-8
1565	Xxxxx-xxxxxx	108-05-4	203-545-4
1566	Xxxxxxxxx (XXX); 2-xxxxx-3-xxxxxx-6-xxxxxxxxxxx	74070-46-5	277-704-1
1567	2-Xxxxxxxxxx-(10-xxxxx-4,4-xxxxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxx)	57583-35-4	260-829-0
1568	Xxxxxxxxxxxxxxx-xxxxxxxxx	753-73-1	212-039-2
1569	4-Xxxxxxxxxxxxxxx	100-40-3	202-848-9
1570	Xxxxxxxxxxx (XXX); 2-(X-xxxxxxxxxxxxxxxxxxx)-3-xxxxxxx-5-xxxxxxxxxxxxxxx-2-xx-1-xx	87820-88-0	618-075-9
1571	Xxxxxxxxxx (ISO); 2-(X-xxxxxxxxxxxxxxxxxx)-3-xxxxxxx-5-(xxxxxxxxxx-2X-xxxxxxxxx-3-xx)xxxxxxxx-2-xx-1-xx	101205-02-1	405-230-9
1572	Xxxxxxxxx (XXX); 3-xxxxx-X-[3-xxxxx-2,6-xxxxxxx-4-(xxxxxxxxxxxxxx)xxxxx]-5-(xxxxxxxxxxxxxx)xxxxxxx-2-xxxx	79622-59-6	616-712-5
1573	Xxxxxxxxxx (XXX); 1-[2-(2,4-xxxxxxxxxxxx)xxxxxx]-1X-1,2,4-xxxxxxx	66246-88-6	266-275-6
1574	Xxxxxxxxxx (XXX); xxxxx-X-[2-(4-xxxxxxxxxxxx)xxxxx]xxxxxxxx	72490-01-8	276-696-7
1575	Xxxxxx	100-42-5	202-851-5
1576	2-(Xxxxxxxxxxxxx)xxxxxxxxxxxxxxx; tetrahydrofurfurylalkohol	97-99-4	202-625-6
1577	Formaldehyd	50-00-0	200-001-8
1578	Paraformaldehyd	30525-89-4	608-494-5
1579	Methandiol, xxxxxxxxxxxxxx	463-57-0	207-339-5
1580	Xxxxxxxxx (XXX); 1-xxxxx-3-[2-xxxx-2-(xxxxxxxxxxxx)xxxxxx]xxxxxxxx	57966-95-7	261-043-0
1581	Xxxxxxxxxxxxxxx, xxxxxxxxxx	—	—
1582	Xxxxxxxxxx (XXX); 2-{2-chlor-4-(methylsulfonyl)-3-[(2,2,2-trifluorethoxy)methyl]benzoyl}cyklohexan-1,3-dion	335104-84-2	608-879-8
1583	1,2-Benzendikarboxylová xxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxx x xxxxxxxx	68515-50-4	271-093-5
1584	Xxxxxxxxxxxxx (XXX); (5s,8s)-3-(2,5-dimethylfenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dek-3-en-4-yl-ethylkarbonát	203313-25-1	606-523-6
1585	Dodemorf-acetát; 4-xxxxxxxxxxxx-2,6-xxxxxxxxxxxxxxxx-4-xxx-xxxxxx	31717-87-0	250-778-2
1586	Xxxxxxxxxxxxxx-xxxxxx; methyl-2-([4-(dimethylamino)-6-(2,2,2-trifluorethoxy)-1,3,5-triazin-2-yl]karbamoylsulfamoyl)-3-methylbenzoát	126535-15-7	603-146-9
1587	Imazalil (XXX); 1-[2-xxxxxxxx-2-(2,4-xxxxxxxxxxxx)xxxxx]-1X-xxxxxxxx	35554-44-0	252-615-0
1588	Xxxxxxxx (ISO); 4-xxxxxxxxxx-2,6-xxxxxxxxxxxxxxxx	1593-77-7	216-474-9
1589	Xxxxxxxx	288-32-4	206-019-2
1590	Xxxxxxx (XXX); 3-cyklohexyl-6,7-dihydro-1H-cyklopenta[d]pyrimidin-2,4(3H,5H)-dion	2164-08-1	218-499-0
1591	Metosulam (XXX); X-(2,6-xxxxxxx-3-xxxxxxxxxxx)-5,7-xxxxxxxxx[1,2,4]xxxxxxxx[1,5-x]xxxxxxxxx-2-xxxxxxxxxx	139528-85-1	604-145-6
1592	2-Xxxxxx-1-(4-xxxxxxxxxxxxxxx)-2-xxxxxxxxxxxxxxx 1-xx	71868-10-5	400-600-6
1593	2,3-Xxxxxxxxxxx-xxxxxxxxxxx	106-91-2	203-441-9
1594	Xxxxxxxxxx (XXX) 8-xxxx-xxxxx-1,4-xxxxxxxxxx[4.5]xxxxx-2-xxxxxxxx(xxxxx)(xxxxxx)xxxx	118134-30-8	601-505-4
1595	Xxxxxxxx; karbonitril	420-04-2	206-992-3
1596	Cyprokonazol (XXX); (2XX,3XX;2XX,3XX)-2-(4-xxxxxxxxxx)-3-xxxxxxxxxxx-1-(1X-1,2,4-xxxxxxx-1-xx)xxxxx-2-xx	94361-06-5	619-020-1
1597	Xxxxxxxx-xxxxxxxxx zeolit	130328-20-0	603-404-0
1598	Uhličitan xxxxxxxxx	513-78-0	208-168-9
1599	Xxxxxxxx xxxxxxxxx	21041-95-2	244-168-5
1600	Xxxxxxxx xxxxxxxxx	10325-94-7	233-710-6
1601	Xxxxxxxxxx-xxxxxxxx xxxxxxx[xxx(xxxxxxxxxxxxx)]xxxxxxx	77-58-7	201-039-8
1602	Xxxxxxxxx; 2-xxxxxx-4-xxxxxxxxxx	120-32-1	204-385-8
1603	Xxxxxxxxxxxx	84-65-1	201-549-0
1604	Xxxxxxxxxxxxxxxxxxxxx kyselina [1]	335-76-2 [1]	206-400-3[1]
	xxxxxxx-xxxxxxxxxxxxxxxxxxxxx [2]	3108-42-7 [2]	221-470-5 [2] [3]
	xxxxxx-xxxxxxxxxxxxxxxxxxxxx [3]	3830-45-3 [3]
1605	X,X′-xxxxxxxxxxxxxxxxxx; X,X′-xxxxxxxxxxxxxxxxxxx; [xxxxxxxxxxx xxxxxxxx x X,X′-xxxxxxxxxxxxxxxxxxxxx]; [XXX] xxxxx xxxxxxxxx xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxxx xxx xxxxxx xx xxxxx je ve xxxxx, jak xx xxxxxxx xx xxx, ≥ 0,1 % xxxxxxxxxxxx	5625-90-1	227-062-3
1606	Xxxxxxx produkty xxxxxxxxxxxxxxxx x 2-xxxxxxxxxxxxxxxxxxx (3:2); [xxxxxxxxxxx xxxxxxxx x 3,3′-methylenbis [5–xxxxxxxxxxxxxxxxx]; [xxxxxxxxxxx xxxxxxxx x oxazolidinu]; [XXX], xxxxx maximální xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxxx xxx xxxxxx xx xxxxx xx xx xxxxx, jak xx xxxxxxx xx xxx, ≥ 0,1 % xxxxxxxxxxxx	—	—
1607	Xxxxxxx produkty paraformaldehydu x 2-xxxxxxxxxxxxxxxxxxx (1:1); [formaldehyd xxxxxxxx x α,α,α-trimethyl-1,3,5-triazin-1,3,5 (2X,4X,6X)-xxxxxxxxxxx]; [XXX], xxxxx xxxxxxxxx xxxxxxxxxx koncentrace xxxxxxxxxxxxx formaldehydu xxx xxxxxx xx xxxxx xx ve xxxxx, xxx xx xxxxxxx xx trh, ≥ 0,1 % xxxxxxxxxxxx	—	—
1608	Xxxxxxxxxxxxxx	60-34-4	200-471-4
1609	Xxxxxxxxxxx (XXX); (1RS,2RS;1RS,2RS)-1-(4-chlorfenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol); α-xxxx-xxxxx-β-(4-xxxxxxxxxxxx)-1X-1,2,4-xxxxxxx-1-xxxxxxx	55219-65-3	259-537-6
1610	Xxxxxxxxxxx (XXX); (Z)-3-(6-chlor-3-pyridylmethyl)-1-3-thiazolidin-2-ylidenkyanamid; {(2X)-3-[(6-xxxxxxxxxxxx-3-xx)xxxxxx]-1,3-xxxxxxxxxxx-2-xxxxxx}xxxxxxxx	111988-49-9	601-147-9
1611	Xxxxxxxxxx (XXX); (X)-1-(xxxxxxxxxxxxxx)xxxxxxxxxxxxxxx (2X)-1-(xxxxxxxxxx)-1-xxxxxxxxx-2-xx-xxxxxxxxxxxxx	16118-49-3	240-286-6“

xxxxxxx 395 xx xxxxxxxxx xxxxx:

Xxxxxxxxxx xxxxx

Xxxxxxxxxxxx xxxxx

Xxxxxxxx xxxxx/XXX

Xxxxx XXX

Xxxxx XX

„395

Xxxxxxxx-8-xx x xxxx xxxxxx

148-24-2

134-31-6

205-711-1

205-137-1“

2)&xxxx;&xxxx;&xxxx;

Xxxxxxx XXX xx xxxx xxxxx:

x)	xxxxxxx 1x, 1x, 7, 13 a 51 xx xxxxxxx;

xxxxxxx 12 xx xxxxxxxxx xxxxx:

Xxxxxxxxxx xxxxx

Xxxxxxxxxxxx látky

Omezení

Znění xxxxxxxx xxxxxxx x upozornění

Chemický xxxxx/XXX

Xxxxx x xxxxxxx xxxxxx xxxxx xxxxxxxx xxxxxxxxxxxx

Xxxxx XXX

Xxxxx XX

Xxxx xxxxxxx, xxxxx těla

Nejvyšší xxxxxxxxxxx v xxxxxxxxx xxxxxxxxxxx x použití

Jiné

„12

Peroxid xxxxxx x xxxxxxx xxxxxxxxxx xxxx xxxxx, xxxxx xxxxxxx xxxxxx xxxxxxxx, xxxxxx xxxxx xxxxxxxx xxxxxxx x xxxxxxx xxxxxxxxx, s xxxxxxxx xxxxxx xxxxx x xxxxxxx II:

—	č. 1397, 1398, 1399

Hydrogen xxxxxxxx

7722-84-1

231-765-0

x)	Xxxxxxxxx na xxxxx

x)	12 % X2X2 (40 xxxxxx), přítomného xxxx xxxxxxxxxx

x) f) Používejte xxxxxx xxxxxxxx.

x) x) x) x)

Xxxxxxxx xxxxxxx xxxxxx.

Xxxxxxxx xxxxx x xxxxx.

Xxx zasažení očí xxxxxxxx vypláchněte xxxxx.

x)	Xxxxxxxxx xx xxxx

x)	4 % X2X2, xxxxxxxxxx xxxx xxxxxxxxxx

x)	Xxxxxxxxx xxx tvrzení xxxxx

x)	2 % X2X2, xxxxxxxxxx xxxx xxxxxxxxxx

x)	Xxxxxxxxx xxx xxxxx xxxxxxx, xxxxxx xxxxx vody, xxxxx xxxxx x xxxxxxxxx xx xxxxxx xxxx xxxxxxxxxx zubů

d)	≤ 0,1 % X2X2, xxxxxxxxxx nebo uvolněného

e)	Přípravky xx bělení xxxx xxxxxxxxxx xxxx

x)	&xx; 0,1 % ≤ 6 % H2O2, xxxxxxxxxx xxxx xxxxxxxxxx

X xxxxxxx xxxxx xxxxxx lékařům. X xxxxxxx xxxxx xxxxxxx xxxx xxx xxxxx xxxxxxx xxxxxxxxx xxxxxx lékařem xx xxxxxx směrnice Xxxxxxxxxx xxxxxxxxxx x Rady 2005/36/XX&xxxx;(*1) xxxx xxx xxxx přímým dohledem, xxxxx je xxxxxxxx xxxxxxxxxx úroveň bezpečnosti.

Poté xxxxxx xxxxxxxxxxxx x xxxxxxxxx xxxxx použití.

Nepoužívat x osob xxxxxxxx 18 xxx.

Xxxxxxxxxxx X2X2 xxxxxxxxxx xxxx xxxxxxxxxx xxxxxxx v procentech.

Nepoužívat x xxxx mladších 18 xxx.

X xxxxxxx xxxxx xxxxxx xxxxxxx. X xxxxxxx xxxxx xxxxxxx musí xxx xxxxx xxxxxxx xxxxxxxxx xxxxx xxxxxx lékařem xxxx xxx xxxx xxxxxx dohledem, xxxxx xx xxxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxxxx.

Xxxx předat xxxxxxxxxxxx k dokončení xxxxx xxxxxxx.

x)	Xxxxxxxxx xxxxxx xxx xxxx

x)	2 % X2X2, přítomného xxxx xxxxxxxxxx

x)	Xxx pro profesionální xxxxxxx.

Xx xxxxxxx xx xxxxx:

„Xxx pro profesionální xxxxxxx.

Xxxxxxxx xxxxx x xxxxx.

Xxx zasažení xxx xxxxxxxx xxxxxxxxxxx xxxxx.

Xxxxxxxx xxxxxxx xxxxxx.“

xxxxxxxx xx xxxx položky, xxxxx xxxxx:

Xxxxxxxxxx xxxxx	Xxxxxxxxxxxx xxxxx				Xxxxxxx			Xxxxx xxxxxxxx použití x xxxxxxxxxx
Xxxxxxxxxx xxxxx	Xxxxxxxx xxxxx/ XXX	Xxxxx x xxxxxxx přísad podle xxxxxxxx xxxxxxxxxxxx	Xxxxx XXX	Xxxxx XX	Xxxx výrobku, části xxxx	Xxxxxxxx xxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxx k xxxxxxx	Xxxx
x	x	x	x	x	x	x	x	x
„311	Xxxxxxx(2,4,6-xxxxxxxxxxxxxxx)xxxxxx xxxx	Xxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxx	75980-60-8	278-355-8	Xxxxxxx xxxxxxx xxxxx	5,0 %	Xxxxxxxxxxxxx xxxxxxx	Xxx xxx xxxxxxxxxxxxx xxxxxxx. Xxxxxxxx xxxxx x xxxx. Xxxxx xxxxxxx xxxxx x xxxxxxx.
312	2-Xxxxxxxxxx	Xxxxxxxx	98-01-1	202-627-7		0,001 %“

3)&xxxx;&xxxx;&xxxx;

Xxxxxxx X&xxxx;xx xxxx xxxxx:

x&xxxx;xxxxx xx xxx 2 nahrazuje xxxxx:

„2.	Xxxxxxx xxxxxxx xxxxxxx obsahující xxxxx xxxxxxx x&xxxx;xxxx xxxxxxx, x&xxxx;xxxxx xx xxxxxxxx xxxxxxxxxxx, musí xxx označeny xxxxxxxxxxx „xxxxxxxx formaldehyd“, xxxxxxxx xxxxxxxxxxx xxxxxxxxxxxx x&xxxx;xxxxxxxx xxxxxxx xxxxxxxx 0,05 %.“;

b)	položky 5, 31, 40 x&xxxx;41 se zrušují;

položka 28 xx xxxxxxxxx xxxxx:

Xxxxxxxxxx xxxxx	Xxxxxxxxxxxx látky				Podmínky			Znění xxxxxxxx xxxxxxx a xxxxxxxxxx
Xxxxxxxxxx xxxxx	Xxxxxxxx xxxxx/XXX	Xxxxx v xxxxxxx přísad xxxxx xxxxxxxx xxxxxxxxxxxx	Xxxxx XXX	Xxxxx XX	Xxxx xxxxxxx, xxxxx xxxx	Xxxxxxxx xxxxxxxxxxx v xxxxxxxxx xxxxxxxxxxx x xxxxxxx	Xxxx
x	x	x	x	x	x	x	x	x
„28	Xxxxxxxxxxxxxxxx-xxxxxxxx-xxxxxxxxxxxx	Xxxxxxxxxxxxxxx xxxxxxxxx	32289-58-0, 27083-27-8, 28757-47-3, 133029-32-0	608-723-9 608-042-7		0,1 %	Xxxxxxxxxx x xxxxxxxxxx, xxx xxxxx xxxx x xxxxxxxx xxxx xxxxxxxxx xxxxxxxxx xxx vdechování.“

(*1) Směrnice Xxxxxxxxxx parlamentu a Xxxx 2005/36/XX xx xxx 7. xxxx 2005 o xxxxxxxx xxxxxxxxx kvalifikací (Úř. xxxx. L 255, 30.9.2005, x.&xxxx;22).“

Plné znění - 32019R0831

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Plné znění - 32019R0831

Na co čekáte? Nečekejte už ani minutu. Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.